# EDGAR Filing Document

**Accession Number:** 0000006176
**File Stem:** 0001193125-26-218133
**Filing Date:** 2026-5
**Character Count:** 143993
**Document Hash:** 36eaf2e474cd1ee2f54fda41b457958c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-218133.hdr.sgml**: 20260512

**ACCESSION NUMBER**: 0001193125-26-218133

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 97

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260512

**DATE AS OF CHANGE**: 20260512

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMPCO PITTSBURGH CORP
- **CENTRAL INDEX KEY:** 0000006176
- **STANDARD INDUSTRIAL CLASSIFICATION:** PUMPS & PUMPING EQUIPMENT [3561]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 251117717
- **STATE OF INCORPORATION:** PA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-00898
- **FILM NUMBER:** 26965795

**BUSINESS ADDRESS:**
- **STREET 1:** 726 BELL AVENUE
- **STREET 2:** SUITE 301
- **CITY:** CARNEGIE
- **STATE:** PA
- **ZIP:** 15106
- **BUSINESS PHONE:** 412-456-4400

**MAIL ADDRESS:**
- **STREET 1:** 726 BELL AVENUE
- **STREET 2:** SUITE 301
- **CITY:** CARNEGIE
- **STATE:** PA
- **ZIP:** 15106

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SCREW & BOLT CORP OF AMERICA
- **DATE OF NAME CHANGE:** 19710518

?xml version='1.0' encoding='ASCII'? 10-Q

 **UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM** 10-Q

------

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**For the quarterly period ended** **March 31,** 2026

 **OR** 

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from to** 

**Commission File Number** 1-898

------

AMPCO-PITTSBURGH CORP**ORATION**![img7687412_0.jpg](img7687412_0.jpg)

------

---

| | |
|:---|:---|
| Pennsylvania | 25-1117717 |
| **(State of**<br>**Incorporation)** | **(I.R.S. Employer**<br>**Identification No.)** |

---

726 Bell Avenue**,** Suite 301

Carnegie**,** Pennsylvania 15106

**(Address of principal executive offices)** 

**(**412**)** 456-4400

**(Registrant's telephone number)** 

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Title of each class | &nbsp;&nbsp;Trading Symbol(s) | &nbsp;&nbsp;Name of each exchange on which registered |
| &nbsp;&nbsp;Common Stock, $1 par value | &nbsp;&nbsp;AP | &nbsp;&nbsp;New York Stock Exchange |

---

&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ | Emerging growth company | &nbsp;&nbsp;&nbsp;&nbsp;☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

On May 7, 2026, 20,326,389 common shares were outstanding.

------

**<u>AMPCO-PITTSBURGH CORPORATION</u>** 

**<u>INDEX</u>** 

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | Page No. |
| Part I – | Financial Information: | Financial Information: |  |
|  | Item 1 – | Financial Statements (Unaudited) |  |
|  |  | [<u>Condensed Consolidated Balance Sheets – March 31, 2026 and December 31, 2025</u>](#condensed_consolidated_balance_sheets) | 3 |
|  |  | [<u>Condensed Consolidated Statements of Operations – Three Months Ended March 31, 2026 and 2025</u>](#condensed_consolidated_statements_operat) | 4 |
|  |  | [<u>Condensed Consolidated Statements of Comprehensive</u>](#condensed_consolidated_statements_compre)[<u>(Loss) Income</u>](#condensed_consolidated_statements_compre)[<u>– Three Months Ended March 31, 2026 and</u>](#condensed_consolidated_statements_compre)[<u>2025</u>](#condensed_consolidated_statements_operat)<br>| 5 |
|  |  | [<u>Condensed Consolidated Statements of Shareholders' Equity – Three Months Ended March 31, 2026 and</u>](#condensed_consolidated_statements_of_sha)[<u>2025</u>](#condensed_consolidated_statements_operat) | 6 |
|  |  | [<u>Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 2026 and</u>](#condensed_consolidated_statements_cash_f)[<u>2025</u>](#condensed_consolidated_statements_operat) | 7 |
|  |  | [<u>Notes to Condensed Consolidated Financial Statements</u>](#notes_to_condensed_consolidated_financia) | 8 |
|  | Item 2 – | [<u>Management's Discussion and Analysis of Financial Condition and Results of Operations</u>](#item_2_managements_discussion_analysis) | 23 |
|  | Item 3 – | [<u>Quantitative and Qualitative Disclosures About Market Risk</u>](#item_3_quantitative_qualitative_disclosu) | 33 |
|  | Item 4 – | [<u>Controls and Procedures</u>](#item_4_controls_procedures) | 33 |
| Part II – | Other Information: | Other Information: |  |
|  | Item 1 – | [<u>Legal Proceedings</u>](#item_1_legal_proceedings) | 34 |
|  | Item 1A – | [<u>Risk Factors</u>](#item_1a_risk_factors) | 34 |
|  | Item 5 – | [<u>Other Information</u>](#item_5) | 34 |
|  | Item 6 – | [<u>Exhibits</u>](#item_6_exhibits) | 35 |
| [<u>Signatures</u>](#signatures) | [<u>Signatures</u>](#signatures) | [<u>Signatures</u>](#signatures) | 36 |

---

------

**<u>PART I – FINANC</u><u>IAL INFORMATION</u>** 

**<u>AMPCO-PITTSBURGH CORPORATION</u>** 

**<u>CONDENSED CONSOLIDAT</u><u>ED BALANCE SHEETS</u>** 

**<u>(UNAUDITED)</u>** 

*(in thousands, except par value)* 

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | December 31, 2025 |
| **Assets** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**9226** | $10703 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade receivables, less allowance for credit losses of $321 as of March 31, 2026 and $242 <br>&nbsp;&nbsp;&nbsp;&nbsp;as of December 31, 2025 | **93581** | 78981 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade receivables from related parties | **2597** | 2390 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | **105090** | 104431 |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance receivable – asbestos | **19000** | 19000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract assets | **7315** | 9790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Estimated recovery - UES-UK (Note 2) | **5370** | 7500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | **6883** | 6825 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | **249062** | 239620 |
| Property, plant and equipment, net | **126318** | 129133 |
| Operating lease right-of-use assets | **4640** | 4673 |
| Insurance receivable – asbestos, less allowance for credit losses of $537 as of March 31, 2026<br>&nbsp;&nbsp;&nbsp;&nbsp; and December 31, 2025 | **103571** | 107838 |
| Deferred income tax assets | **3896** | 3898 |
| Intangible assets, net | **4459** | 4631 |
| Investments in joint ventures | **835** | 835 |
| Other noncurrent assets | **4426** | 4727 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $**497207** | $495355 |
| **Liabilities and Shareholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $**49167** | $46268 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable to related parties | **773** | 1827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued payrolls and employee benefits | **15246** | 13357 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt – current portion | **18788** | 15723 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities – current portion | **946** | 946 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos liability – current portion | **28000** | 28000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer-related liabilities | **21758** | 16522 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | **7416** | 7816 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | **142094** | 130459 |
| Employee benefit obligations | **20447** | 21841 |
| Asbestos liability | **164969** | 170332 |
| Long-term debt | **115307** | 117903 |
| Noncurrent operating lease liabilities | **3694** | 3727 |
| Deferred income tax liabilities | **332** | 326 |
| Other noncurrent liabilities | **2788** | 2804 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | **449631** | 447392 |
| Commitments and contingent liabilities (Note 10) |  |  |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock – par value $1; authorized 40,000 shares; issued and outstanding <br>&nbsp;&nbsp;&nbsp;&nbsp;20,237 shares as of March 31, 2026 and December 31, 2025 | **20237** | 20237 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | **179524** | 179232 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained deficit | **(139493)** | (138626) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(28944)** | (28204) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Ampco-Pittsburgh shareholders' equity | **31324** | 32639 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interest | **16252** | 15324 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | **47576** | 47963 |
| Total liabilities and shareholders' equity | $**497207** | $495355 |

---

See Notes to Condensed Consolidated Financial Statements.

------

**<u>AMPCO-PITTSBURGH CORPORATION</u>**

**<u>CONDENSED CONSOLIDATED S</u><u>TATEMENTS OF OPERATIONS</u>** 

**<u>(UNAUDITED)</u>** 

*(in thousands, except per share amounts)* 

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Net sales: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $**103131** | $99226 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales to related parties | **5196** | 5039 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net sales | **108327** | 104265 |
| Operating costs and expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Costs of products sold (excluding depreciation and amortization) | **86755** | 82104 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling and administrative | **13884** | 13659 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **4258** | 4636 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deconsolidation Charge (Note 2) | **875** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on disposal of assets | **(7)** | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating costs and expenses | **105765** | 100415 |
| Income from operations | **2562** | 3850 |
| Other expense – net: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | **(2723)** | (2726) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income – net | **596** | 826 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense – net | **(2127)** | (1900) |
| Income before income taxes | **435** | 1950 |
| Income tax provision | **(585)** | (59) |
| Net (loss) income | **(150)** | 1891 |
| Less: Net income attributable to noncontrolling interest | **717** | 749 |
| Net (loss) income attributable to Ampco-Pittsburgh | $**(867)** | $1142 |
| Net (loss) income per share attributable to Ampco-<br> Pittsburgh common shareholders: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $**(0.04)** | $0.06 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $**(0.04)** | $0.06 |
| Weighted-average number of common shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | **20237** | 19980 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | **20237** | 20167 |

---

See Notes to Condensed Consolidated Financial Statements.

------

**<u>AMPCO-PITTSBURGH CORPORATION</u>** 

**<u>CONDENSED CONSOLIDATED STATE</u><u>MENTS OF COMPREHENSIVE (LOSS) INCOME</u>**

**<u>(UNAUDITED)</u>** 

*(in thousands)* 

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Net (loss) income | $**(150)** | $1891 |
| Other comprehensive (loss) income, net of income tax where applicable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments for changes in: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation | **(563)** | 4125 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrecognized employee benefit costs (including effects of foreign currency translation) | **6** | (399) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fair value of cash flow hedges | **163** | 780 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification adjustments for items included in net (loss) income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of unrecognized employee benefit costs | **(67)** | (65) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Settlement of cash flow hedges | **(68)** | (59) |
| Other comprehensive (loss) income | **(529)** | 4382 |
| Comprehensive (loss) income | **(679)** | 6273 |
| Less: Comprehensive income attributable to noncontrolling interest | **928** | 820 |
| Comprehensive (loss) income attributable to Ampco-Pittsburgh | $**(1607)** | $5453 |

---

See Notes to Condensed Consolidated Financial Statements.

------

**<u>AMPCO-PITTSBURGH CORPORATION</u>** 

**<u>CONDENSED CONSOLIDATED STATE</u><u>MENTS OF SHAREHOLDERS' EQUITY</u>**

**<u>(UNAUDITED)</u>**

*(in thousands)*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common<br>Stock** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Deficit** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Noncontrolling<br>Interest** | **Total** |
| **<u>Three Months Ended March 31, 2026</u>** |  |  |  |  |  |  |
| **Balance at January 1, 2026** | $**20237** | $**179232** | $**(138626)** | $**(28204)** | $**15324** | $**47963** |
| **Stock-based compensation** |  | **292** |  |  |  | **292** |
| **Comprehensive income (loss):** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net (loss) income** |  |  | **(867)** |  | **717** | **(150)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Other comprehensive (loss) income** |  |  |  | **(740)** | **211** | **(529)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Comprehensive income (loss)** |  |  |  |  | **928** | **(679)** |
| **Balance at March 31, 2026** | $**20237** | $**179524** | $**(139493)** | $**(28944)** | $**16252** | $**47576** |
| <u>Three Months Ended March 31, 2025</u> |  |  |  |  |  |  |
| Balance at January 1, 2025 | $19980 | $178298 | $(72559) | $(66836) | $12208 | $71091 |
| Stock-based compensation |  | 306 |  |  |  | 306 |
| Comprehensive income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  | 1142 |  | 749 | 1891 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  | 4311 | 71 | 4382 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income |  |  |  |  | 820 | 6273 |
| Balance at March 31, 2025 | $19980 | $178604 | $(71417) | $(62525) | $13028 | $77670 |

---

See Notes to Condensed Consolidated Financial Statements.

------

S

**<u>AMPCO-PITTSBURGH CORPORATION</u>** 

**<u>CONDENSED CONSOLIDATED S</u><u>TATEMENTS OF CASH FLOWS</u>** 

**<u>(UNAUDITED)</u>** 

*(in thousands)* 

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Net cash flows provided by (used in) operating activities | $**1647** | $(5280) |
| Cash flows used in investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | **(3385)** | (2200) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from government grants, used for purchase of equipment |  | 323 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of property, plant and equipment | **10** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of long-term marketable securities | **(2)** | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of long-term marketable securities | **144** | 168 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash flows used in investing activities | **(3233)** | (1711) |
| Cash flows provided by (used in) financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from revolving credit facility | **3041** | 4666 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on revolving credit facility | **(1500)** | (5666) |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment of debt principal | **(1359)** | (727) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash flows provided by (used in) financing activities | **182** | (1727) |
| Effect of exchange rate changes on cash and cash equivalents | **(73)** | 420 |
| Net decrease in cash and cash equivalents | **(1477)** | (8298) |
| Cash and cash equivalents at beginning of period | **10703** | 15427 |
| Cash and cash equivalents at end of period | $**9226** | $7129 |
| Supplemental information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax payments (net of refunds) | $**464** | $487 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest payments | $**2301** | $2331 |
| Non-cash investing and financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment in accounts payable | $**1640** | $310 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease right-of-use assets exchanged for lease liabilities | $**—** | $23 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets exchanged for lease liabilities | $**137** | $633 |

---

See Notes to Condensed Consolidated Financial Statements.

------

**<u>AMPCO-PITTSBURGH CORPORATION</u>** 

**<u>NOTES TO CONDENSED CONSOLID</u><u>ATED FINANCIAL STATEMENTS</u>** 

**<u>(UNAUDITED)</u>** 

*(in thousands, except per share amounts)* 

**<u>Overview of the Business</u>**

Ampco-Pittsburgh Corporation (the "Corporation") manufactures and sells highly engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments – the *Forged and Cast Engineered Products* ("FCEP") segment and the *Air and Liquid Processing* ("ALP") segment. This segment presentation is consistent with how the Corporation's chief operating decision-maker ("CODM") evaluates financial performance and makes resource allocation and strategic decisions about the business ([<u>Note 18</u>](#note_18)).

**<u>Note 1 – Unaudited Condensed Consolidated Financial Statements</u>** 

The unaudited condensed consolidated balance sheet as of March 31, 2026 and the unaudited condensed consolidated statements of operations, comprehensive (loss) income, shareholders' equity, and cash flows for the three months ended March 31, 2026 and 2025, have been prepared by the Corporation. In the opinion of management, all adjustments, consisting of only normal and recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the periods presented, have been made. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the operating results expected for the full year.

Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the Corporation's latest Annual Report on Form 10-K.

<u>Recently Adopted Accounting Pronouncements</u>

In September 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2025-6, *Intangibles - Goodwill and Other - Internal-Use Software - Targeted Improvements to the Accounting for Internal-Use Software*. The guidance modifies when an organization begins capitalizing internal use software costs. The Corporation adopted the standard January 1, 2026. ASU 2025-6 did not have an effect on the Corporation's condensed consolidated financial statements as of the date of adoption.

<u>Recently Issued Accounting Pronouncements</u>

In December 2025, the FASB issued ASU 2025-10, *Accounting for Government Grants Received by Business Entities.* ASU 2025-10 provides authoritative guidance about the recognition, measurement, and presentation of a grant received by a business entity from a government, including a grant related to an asset that is conditioned on the purchase, construction, or acquisition of an asset such as a long-lived asset. The guidance becomes effective for the Corporation's annual period beginning January 1, 2029, with early adoption permitted. The Corporation is currently evaluating the impact this new standard will have on its consolidated financial position, results of operations and cash flows.

In November 2024, the FASB issued ASU 2024-03, *Income Statement - Disaggregation of Income Statement Expenses*. The guidance requires tabular disclosure of certain expenses included in costs of products sold and selling and administrative expenses, such as purchases of inventory and employee compensation, and qualitative description of certain other costs. The guidance becomes effective for the Corporation's annual period beginning January 1, 2027 and interim periods beginning January 1, 2028. The Corporation is currently evaluating the impact this new standard will have on its annual disclosures in its consolidated financial statements for the year ending December 31, 2027 and interim disclosures thereafter. It will not, however, impact the Corporation's consolidated financial position, results of operations or cash flows.

**<u>Note 2 -</u> <u>U</u><u>ES-UK</u>**

On October 14, 2025, (the "Filing Date"), the Directors of Union Electric Steel UK Limited ("UES-UK"), an indirect wholly owned subsidiary of the Corporation, filed a Notice of Appointment with the High Court of Justice, Business and Property Courts at Leeds formally appointing certain insolvency practitioners of FRP Advisory Trading Limited as administrators of UES-UK (collectively, the "Administrators"). This action was confined to UES-UK exclusively and did not affect the Corporation or any of its other subsidiaries. As of the Filing Date, UES-UK was in administration and its affairs, business and property were being managed by the Administrators (the "Structured Insolvency").

Through October 13, 2025, the date immediately prior to the Filing Date, the operating results of UES-UK are included in the condensed consolidated operating results of the Corporation. Effective as of the Filing Date, the Corporation no longer consolidates

------

the operating results of UES-UK, as the Corporation no longer has decision-making control over UES-UK. As of the Filing Date, the Corporation (i) wrote down its investment in UES-UK to its estimated fair value; (ii) recognized the other comprehensive losses of UES-UK deferred in accumulated other comprehensive loss; and (iii) established an estimated recovery for the amount of funds expected to be returned to the lenders under the Corporation's Second Amended and Restated Revolving Credit, Term Loan and Security Agreement (the "Credit Agreement"), if any, after the costs and expenses of the Structured Insolvency, since the accounts receivables, inventories, and equipment of UES-UK were held as collateral under the Credit Agreement (the "Estimated Recovery").

As of December 31, 2025, the Estimated Recovery equaled $7,500. In January 2026, the Administrators distributed $1,255, which was returned to the lenders under the Credit Agreement and reduced the Corporation's balance outstanding under the Credit Agreement. As of March 31, 2026, the Corporation evaluated the collectability of the remaining Estimated Recovery and, based on updated information received from the Administrators including lower funds expected to be available for future distributions, reduced the Estimated Recovery by $875 which is recognized as a Deconsolidation Charge in the accompanying condensed consolidated statements of operations.

Changes in the Estimated Recovery for the three months ended March 31, 2026 were as follows:

---

| | |
|:---|:---|
|  | **Three Months Ended March 31, 2026** |
| Balance at beginning of the period | $**7500** |
| Cash received | **(1255)** |
| Change in the Estimated Recovery | **(875)** |
| Balance at end of the period | $**5370** |

---

The Corporation will continue to evaluate the collectability of the Estimated Recovery and will adjust the Estimated Recovery based on facts and circumstances at each reporting date. If it is determined the Estimated Recovery is expected to be lower than currently estimated, then the Estimated Recovery would be reduced and a charge to net (loss) income would be recorded. Similarly, if it is determined the Estimated Recovery is expected to be higher than currently estimated, then the Estimated Recovery would be increased and a credit to net (loss) income would be recorded. Any recovery will be distributed in the order of priority set forth in the Insolvency Act 1986.

**<u>Note 3 – Inven</u><u>tories</u>** 

At March 31, 2026 and December 31, 2025, substantially all inventories were valued using the first-in, first-out method. Inventories were comprised of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31,<br>2026** | December 31,<br>2025 |
| Raw materials | $**38230** | $38766 |
| Work-in-process | **40891** | 39930 |
| Finished goods | **19198** | 19069 |
| Supplies | **6771** | 6666 |
| Inventories | $**105090** | $104431 |

---

**<u>Note 4</u> <u>– Contract Assets</u>**

Changes in contract assets were comprised of the following:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Balance at beginning of the period | $**9790** | $8486 |
| Satisfaction of existing contracts | **(18705)** | (16323) |
| Additional revenue earned on new and existing contracts | **16267** | 13236 |
| Other, primarily changes in foreign currency exchange rates | **(37)** | 90 |
| Balance at end of the period | $**7315** | $5489 |

---

------

**<u>Note 5 – Property, Pl</u><u>ant and Equipment</u>** 

Property, plant and equipment were comprised of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31,<br>2026** | December 31,<br>2025 |
| Land and land improvements | $**9216** | $9321 |
| Buildings and leasehold improvements | **69934** | 70319 |
| Machinery and equipment | **347194** | 347030 |
| Construction-in-progress | **6903** | 6088 |
| Other | **6447** | 6447 |
|  | **439694** | 439205 |
| Accumulated depreciation and amortization | **(313376)** | (310072) |
| Property, plant and equipment, net | $**126318** | $129133 |

---

Certain property, plant and equipment are held as collateral including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Certain of the machinery and equipment with a book value equal to approximately $24,239 at March 31, 2026, purchased with proceeds from the equipment finance facility ([<u>Note 8</u>](#note_8)), are held as collateral for the equipment financing facility.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Certain land and land improvements and buildings and leasehold improvements with a book value equal to approximately $55,510 are included in the sale-leaseback financing transactions and Disbursement Agreement ([<u>Note 8</u>](#note_8)). Title to these assets lies with the lender; however, since the transactions qualified as financing transactions, versus sales, the assets remain recorded on the Corporation's condensed consolidated balance sheets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The remaining assets, other than real property, are pledged as collateral for the Corporation's revolving credit facility and Equipment Term Notes ([<u>Note 8</u>](#note_8)).

The gross value of assets under finance leases and the related accumulated depreciation approximated $3,557 and $1,858, respectively, as of March 31, 2026 and $3,795 and $1,966, respectively, at December 31, 2025.

Depreciation expense approximated $4,200 and $4,550, including depreciation of assets under finance leases of approximately $94 and $77, for the three months ended March 31, 2026 and 2025, respectively.

**<u>Not</u><u>e 6 – Intangible Assets</u>** 

Intangible assets were comprised of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31,<br>2026** | December 31,<br>2025 |
| Customer relationships | $**4284** | $5743 |
| Developed technology | **4063** | 4136 |
| Trade name | **2335** | 2395 |
|  | **10682** | 12274 |
| Accumulated amortization | **(6223)** | (7643) |
| Intangible assets, net | $**4459** | $4631 |

---

The trade name is an indefinite-lived asset and, accordingly, is not subject to amortization. The fluctuation between the periods is due to changes in foreign currency exchange rates. Changes in intangible assets consisted of the following:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Balance at beginning of the period | $**4631** | $4255 |
| Amortization of intangible assets | **(58)** | (86) |
| Other, primarily impact from changes in foreign currency exchange rates | **(114)** | 325 |
| Balance at end of the period | $**4459** | $4494 |

---

------

**<u>Note 7</u> <u>– Customer-Related Liabilities</u>** 

Customer-related liabilities as of March 31, 2026 and December 31, 2025 primarily include liabilities for product warranty claims and deposits received on future orders. The Corporation provides a limited warranty on its products, known as an "assurance-type" warranty, and may issue credit notes or replace products free of charge for valid claims. A warranty is considered an assurance-type warranty if it provides the customer with assurance that the product will function as intended. Historically, warranty claims have been insignificant. The Corporation records a provision for estimated product warranties at the time the underlying sale is recorded. The provision is based on historical experience as a percentage of sales adjusted for probable and known claims.

Changes in the liability for product warranty claims consisted of the following:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Balance at beginning of the period | $**5350** | $5423 |
| Satisfaction of warranty claims | **(226)** | (855) |
| Provision for warranty claims, net | **665** | 237 |
| Other, primarily impact from changes in foreign currency exchange rates | **(145)** | 253 |
| Balance at end of the period | $**5644** | $5058 |

---

Customer deposits represent amounts collected from, or invoiced to, a customer in advance of revenue recognition when necessary to secure the right to a specific product. The liability for customer deposits is reversed when the Corporation satisfies its performance obligations and control of the inventory transfers to the customer, typically when title transfers. The majority of performance obligations related to customer deposits are expected to be satisfied in less than one year. Performance obligations related to customer deposits expected to be satisfied beyond one year are classified as a noncurrent liability on the condensed consolidated balance sheets.

Changes in customer deposits consisted of the following:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Balance at beginning of the period | $**12707** | $21503 |
| Satisfaction of performance obligations | **(4827)** | (9836) |
| Receipt of additional deposits | **9618** | 11369 |
| Other, primarily impact from changes in foreign currency exchange rates | **(8)** | 49 |
| Balance at end of the period | **17490** | 23085 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposits - Other noncurrent liabilities | **(2700)** | (2746) |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposits - Customer-related liabilities | $**14790** | $20339 |

---

**<u>Note</u> <u>8 – Debt</u>** 

Borrowings were comprised of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31,<br>2026** | December 31,<br>2025 |
| Revolving credit facility | $**53760** | $52219 |
| Sale-leaseback financing obligations | **46475** | 46296 |
| Equipment financing facility | **14066** | 14633 |
| Equipment Term Notes | **9416** | 9898 |
| Industrial Revenue Bonds | **9191** | 9191 |
| Finance lease liabilities | **1187** | 1389 |
| Outstanding borrowings | **134095** | 133626 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt – current portion | **(18788)** | (15723) |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt | $**115307** | $117903 |

---

The current portion of debt includes primarily the Industrial Revenue Bonds ("IRBs"), swing loans under the revolving credit facility and principal payments due during the next 12 months. Although the IRBs begin to become due in late 2027, the bonds can be put back to the Corporation on short notice if they are not able to be remarketed; accordingly, the IRBs are classified as a current liability, although the Corporation considers the likelihood of the bonds being put back to the Corporation to be remote. By definition, swing loans are temporary advances under the revolving credit facility and short-term in nature. Accordingly, swing loans are classified as a

------

current liability until the amount is either repaid, as customers remit payments, or, if elected by the Corporation, refinanced as a longer-term loan under the revolving credit facility. The swing loan balance outstanding was $4,260 and $1,219 at March 31, 2026 and December 31, 2025, respectively.

<u>Revolving Credit Facility</u>

On June 25, 2025, the Corporation entered into the Credit Agreement, amending its previous revolving credit and security agreement. The Credit Agreement provides for a $100,000 senior secured asset-based revolving credit facility (the "Revolving Credit Facility") and $13,500 under the Equipment Term Notes (see below).

The Revolving Credit Facility can be increased to $125,000 at the option of the Corporation and with the approval of the lenders and provides sublimits for letters of credit not to exceed $40,000 and European borrowings not to exceed $30,000. Borrowings under the Revolving Credit Facility will bear interest at the Secured Overnight Financing Rate ("SOFR") plus an applicable margin ranging between 2.00% and 2.50%. The maturity date for the Revolving Credit Facility is June 25, 2030 and, subject to other terms and conditions of the Credit Agreement, would become due on that date.

As of March 31, 2026, the Corporation had outstanding borrowings under the Revolving Credit Facility of $53,760. The average interest rate under the Revolving Credit Facility and, for 2025, the previous revolving credit and security agreement approximated 6.44% and 7.03% for the three months ended March 31, 2026 and 2025, respectively. The Corporation also utilizes a portion of the Revolving Credit Facility for letters of credit ([<u>Note 10</u>](#note_10)). As of March 31, 2026, the remaining availability under the Revolving Credit Facility approximated $30,825, net of standard availability reserves. Debt issuance costs of $891 were incurred in 2025 related to amending the Credit Agreement and are being amortized over the remaining term of the agreement.

Borrowings outstanding under the Revolving Credit Facility are collateralized by a first priority perfected security interest in substantially all of the accounts receivable and inventories of the Corporation and its subsidiaries. The Credit Agreement contains customary affirmative and negative covenants and limitations, including, but not limited to, investments in certain subsidiaries, payment of dividends, incurrence of additional indebtedness and guaranties, and acquisitions and divestitures. In addition, the Corporation must maintain a certain level of excess availability or otherwise maintain a minimum Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of not less than 1.05 to 1.00. The Corporation was in compliance with the applicable bank covenants as of March 31, 2026.

<u>Sale-Leaseback Financing Obligations</u>

In September 2018, Union Electric Steel Corporation ("UES"), an indirect wholly owned subsidiary of the Corporation, completed a sale-leaseback financing transaction with Store Capital Acquisitions, LLC ("STORE") for certain of its real property, including its manufacturing facilities in Valparaiso, Indiana and Burgettstown, Pennsylvania, and its manufacturing facility and corporate headquarters located in Carnegie, Pennsylvania (the "UES Properties").

In August 2022, Air & Liquid Systems Corporation ("Air & Liquid"), a wholly owned subsidiary of the Corporation, completed a sale-leaseback financing transaction with STORE for certain of its real property, including its manufacturing facilities in Lynchburg, Virginia and Amherst, Virginia. In October 2022, Air & Liquid completed a sale-leaseback financing transaction with STORE for its real property, including its manufacturing facility, located in North Tonawanda, New York (collectively with the Virginia properties, the "ALP Properties").

In connection with the August 2022 sale-leaseback financing transaction, and as modified by the October 2022 sale-leaseback financing transaction, UES and STORE entered into a Second Amended and Restated Master Lease Agreement (the "Restated Lease"), which amended and restated the existing lease agreement between UES and STORE. Pursuant to the Restated Lease, UES will lease the ALP Properties and the UES Properties (collectively, the "Properties"), subject to the terms and conditions of the Restated Lease, and UES will sublease the ALP Properties to Air & Liquid on the same terms as the Restated Lease. The Restated Lease provides for an initial term of 20 years; however, UES may extend the lease for the Properties for four successive periods of five years each. If fully extended, the Restated Lease would expire in August 2062. UES also has the option to repurchase the Properties, which it may, and intends to, exercise in 2032, for a price equal to the greater of (i) the Fair Market Value of the Properties or (ii) 115% of Lessor's Total Investment, with such terms defined in the Restated Lease.

In August 2022, in connection with the Restated Lease, UES and STORE entered into a Disbursement Agreement pursuant to which STORE agreed to provide up to $2,500 to UES towards certain leasehold improvements in the Carnegie, Pennsylvania manufacturing facility. In June 2023, UES received $2,500 of proceeds from the Disbursement Agreement. The annual payments for the Properties (the "Base Annual Rent") have been adjusted to repay the $2,500 over the balance of the initial term of the Restated Lease of 20 years. Advances under the Disbursement Agreement are secured by a first priority security interest in the leasehold improvements.

At March 31, 2026, the Base Annual Rent, including the Disbursement Agreement, is equal to $3,795, payable in equal monthly installments. Each October through 2052, the Base Annual Rent will increase by an amount equal to the lesser of 2.04% or 1.25 times

------

the change in the consumer price index, as defined in the Restated Lease. The Base Annual Rent during the remaining ten years of the Restated Lease will equal the Fair Market Rent, as defined in the Restated Lease.

The Restated Lease and the Disbursement Agreement contain certain representations, warranties, covenants, obligations, conditions, indemnification provisions, and termination provisions customary for those types of agreements. The Corporation was in compliance with the applicable covenants as of March 31, 2026.

The effective interest rate approximated 8.32% and 8.26% for the three months ended March 31, 2026 and 2025, respectively.

<u>Equipment Financing Facility</u>

In September 2022, UES and Clarus Capital Funding I, LLC ("Clarus") entered into a Master Loan and Security Agreement, pursuant to which UES could borrow up to $20,000 to finance certain equipment purchases associated with a capital program at certain of its locations. Each borrowing constituted a secured loan transaction (each, a "Term Note"). Each Term Note has a term of 84 months. As of March 31, 2026, monthly payments of principal and interest approximate $293, which continue through mid-2031.

Interest on each Term Note accrues at an annual fixed rate ranging between 8.40% and 9.22%. The effective interest rates approximated 8.55% and 8.65% for the three months ended March 31, 2026 and 2025, respectively. Each Term Note is secured by a first priority security interest in and to all of UES' rights, title and interests in the underlying equipment.

<u>Equipment Term Notes</u>

Under the Credit Agreement, the Corporation may borrow up to $13,500 pursuant to senior secured term notes (the "Equipment Term Notes"). On June 25, 2025, the Corporation borrowed $13,500 with such proceeds used to paydown borrowings under the Revolving Credit Facility. The Equipment Term Notes are payable in equal monthly installments of principal of $161 commencing August 1, 2025, and continuing on the first day of each month through June 2030, followed by the sixtieth payment of all unpaid principal, accrued and unpaid interest and all unpaid fees, unless otherwise refinanced.

Borrowings under the Equipment Term Notes bear interest at SOFR plus an applicable margin ranging between 3.00% and 3.50%. The effective interest rate approximated 7.30% for the three months ended March 31, 2026. The Equipment Term Notes are secured by certain equipment of the Corporation that secured the previous revolving credit facility.

<u>Industrial Revenue Bonds ("IRBs")</u>

The Corporation has two IRBs outstanding: (i) $7,116 taxable IRB maturing November 1, 2027, interest at a floating rate which averaged 3.72% and 4.43% for the three months ended March 31, 2026 and 2025, respectively, and (ii) $2,075 tax-exempt IRB maturing March 1, 2029, interest at a floating rate which averaged 2.39% and 2.97% for the three months ended March 31, 2026 and 2025, respectively. The IRBs are secured by letters of credit of equivalent amounts and are remarketed periodically at which time the interest rates are reset. If the IRBs are not able to be remarketed, although considered a remote possibility by the Corporation, the bondholders can seek reimbursement immediately from the letters of credit; accordingly, the IRBs are recorded as current debt on the condensed consolidated balance sheets.

**<u>Note 9 –</u> <u>Pension and Other Postretirement Benefits</u>** 

Contributions to the Corporation's employee benefit plans were as follows:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| U.S. defined benefit pension plans | $**598** | $796 |
| U.S. nonqualified defined benefit pension plans (e.g. payments) | $**167** | $192 |
| Foreign defined benefit pension plans | $**77** | $106 |
| Other postretirement benefits (e.g., net payments) | $**69** | $85 |
| Foreign defined contribution pension plans | $**60** | $70 |
| U.S. defined contribution plan | $**472** | $854 |

---

------

Net periodic pension and other postretirement benefit costs included the following components:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
| U.S. Defined Benefit Pension Plans <sup>(a)</sup> | **2026** | 2025 |
| Service cost | $**5** | $7 |
| Interest cost | **1989** | 2249 |
| Expected return on plan assets | **(2493)** | (2871) |
| Amortization of actuarial loss | **266** | 142 |
| Net benefit income | $**(233)** | $(473) |

---

*(a) Includes the nonqualified defined benefit pension plans.* 

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
| Foreign Defined Benefit Pension Plans<sup>(b)</sup> | **2026** | 2025 |
| Service cost | $**9** | $26 |
| Interest cost | **48** | 457 |
| Expected return on plan assets |  | (525) |
| Amortization of prior service credit |  | (70) |
| Amortization of actuarial loss | **3** | 197 |
| Net benefit expense | $**60** | $85 |

---

*(b) Includes UES-UK for the three months ended March 31, 2025.*

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
| Other Postretirement Benefit Plans | **2026** | 2025 |
| Service cost | $**34** | $42 |
| Interest cost | **88** | 90 |
| Amortization of prior service credit | **(256)** | (256) |
| Amortization of actuarial gain | **(80)** | (78) |
| Net benefit income | $**(214)** | $(202) |

---

**<u>Note 10 – Com</u><u>mitments and Contingent Liabilities</u>** 

As of March 31, 2026:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Outstanding standby and commercial letters of credit and bank guarantees equaled $11,855, of which more than half serves as collateral for the IRB debt,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Outstanding surety bonds approximated $3,562 (SEK 33,900), which guarantee certain pension commitments of certain of the Corporation's foreign subsidiaries under a credit insurance arrangement, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Outstanding Corporate guarantees approximated $1,681 (SEK 16,000), which guarantee certain obligations of one of the Corporation's foreign subsidiaries with its local banking partner.

At March 31, 2026, commitments for future capital expenditures approximated $8,400, which is expected to be spent over the next 12-18 months.

See [<u>Note 12</u>](#note_12) for derivative instruments, [<u>Note 15</u>](#note_15) for litigation and [<u>Note 16</u>](#note_16) for environmental matters.

------

**<u>Note 11 – Accumul</u><u>ated Other Comprehensive Loss</u>** 

Net change and ending balances for the various components of accumulated other comprehensive loss as of and for the three months ended March 31, 2026 and 2025 are summarized below. All amounts are net of tax where applicable.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Foreign<br>Currency<br>Translation | Unrecognized<br>Employee<br>Benefit Costs | Cash Flow<br>Hedges | Total <br>Accumulated Other <br>Comprehensive Loss | Less:<br>Noncontrolling<br>Interest | Accumulated Other <br>Comprehensive Loss<br>Attributable to Ampco-Pittsburgh |
| **Balance at January 1, 2026** | $**863** | $**(29405)** | $**116** | $**(28426)** | $**(222)** | $**(28204)** |
| **Net change** | **(563)** | **(61)** | **95** | **(529)** | **211** | **(740)** |
| **Balance at March 31, 2026** | $**300** | $**(29466)** | $**211** | $**(28955)** | $**(11)** | $**(28944)** |
| Balance at January 1, 2025 | $(27691) | $(39856) | $(102) | $(67649) | $(813) | $(66836) |
| Net change | 4125 | (464) | 721 | 4382 | 71 | 4311 |
| Balance at March 31, 2025 | $(23566) | $(40320) | $619 | $(63267) | $(742) | $(62525) |

---

The following summarizes the line items affected on the condensed consolidated statements of operations for components reclassified from accumulated other comprehensive loss. Amounts in parentheses represent credits to net (loss) income.

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Amortization of unrecognized employee benefit costs: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other loss – net | $**(67)** | $(65) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net of tax | $**(67)** | $(65) |
| Settlements of cash flow hedges: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization (foreign currency purchase contracts) | $**(6)** | $(6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Costs of products sold (excluding depreciation and <br>amortization) (futures contracts – copper and aluminum) | **(64)** | (55) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total before income tax | **(70)** | (61) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect | **2** | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net of tax | $**(68)** | $(59) |

---

The income tax effect associated with the various components of other comprehensive (loss) income for the three months ended March 31, 2026 and 2025 is summarized below. Amounts in parentheses represent credits to net (loss) income when reclassified to earnings. Certain amounts have no tax effect due to the Corporation having a valuation allowance recorded against the deferred income tax assets for the jurisdiction where the income or expense is recognized. Foreign currency translation adjustments exclude the effect of income taxes since earnings of non-U.S. subsidiaries are deemed to be reinvested for an indefinite period of time.

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Income tax effect associated with changes in: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrecognized employee benefit costs | $**—** | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value of cash flow hedges | $**6** | $21 |
| Income tax effect associated with reclassification adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of unrecognized employee benefit costs | $**—** | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Settlement of cash flow hedges | $**2** | $2 |

---

**<u>Note 12 – Derivative Instruments</u>** 

Certain divisions of the ALP segment are subject to risk from increases in the price of commodities (aluminum and copper) used in the production of inventory. To minimize this risk, futures contracts are entered into which are designated as cash flow hedges. In March 2025, given the dramatic escalation in the price of copper futures and sufficient supply of copper, the Corporation terminated its existing futures contracts for copper resulting in a pre-tax termination gain of approximately $559. The termination gain was

------

reclassified to earnings throughout 2025 as the projected sales occurred. At March 31, 2026, approximately 67%, or $1,192, of anticipated aluminum purchases over the next eight months are hedged. At March 31, 2025, approximately 50%, or $394, of anticipated aluminum purchases over the next four months were hedged.

The Corporation periodically enters into purchase commitments to cover a portion of its anticipated natural gas and electricity usage. The commitments qualify as normal purchases and, accordingly, are not reflected on the condensed consolidated balance sheets. At March 31, 2026, the Corporation has purchase commitments covering approximately 25%, or $680, of anticipated natural gas usage through December 31, 2026 for one of its subsidiaries and approximately 36%, or $1,678, of anticipated electricity usage through December 31, 2027 for another one of its subsidiaries. At March 31, 2025, the Corporation had purchase commitments covering approximately 26%, or $1,198, of anticipated natural gas usage through December 31, 2025 for two of its subsidiaries and approximately 32%, or $945 of anticipated electricity usage through December 31, 2025 for two of its subsidiaries. Purchases of natural gas and electricity under previously existing commitments equaled $549 and $1,124 for the three months ended March 31, 2026 and 2025, respectively.

The Corporation previously entered into foreign currency purchase contracts to manage the volatility associated with euro-denominated progress payments to be made for certain machinery and equipment. Upon occurrence of an anticipated purchase and placement of the underlying fixed asset in service, the foreign currency purchase contract was settled and the change in fair value of the foreign currency purchase contract was deferred in accumulated other comprehensive loss and is being reclassified to earnings (depreciation and amortization expense) over the life of the underlying asset (approximately 15 years, through 2026).

No portion of the existing cash flow hedges is considered to be ineffective, including any ineffectiveness arising from the unlikelihood of an anticipated transaction to occur. Additionally, no amounts have been excluded from assessing the effectiveness of a hedge. The Corporation does not enter into derivative transactions for speculative purposes and, therefore, holds no derivative instruments for trading purposes.

Gains on foreign exchange transactions included in other income – net equaled $205 and 221 for the three months ended March 31, 2026 and 2025, respectively.

The change in the fair value of the cash flow contracts is recorded as a component of accumulated other comprehensive loss. The balances as of March 31, 2026 and 2025 and the amounts recognized as and reclassified from accumulated other comprehensive loss for each of the periods are summarized below. Amounts are after tax where applicable. Certain amounts recognized as comprehensive (loss) income or reclassified from accumulated other comprehensive loss have no tax effect due to the Corporation having a valuation allowance recorded against the deferred income tax assets for the jurisdiction where the income or expense is recognized.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Beginning of<br>the Period | Recognized | Reclassified | End of<br>the Period |
| **<u>Three Months Ended March 31, 2026</u>** |  |  |  |  |
| **Foreign currency purchase contracts** | $**27** | $**—** | $**6** | $**21** |
| **Futures contracts – copper and aluminum** | **89** | **163** | **62** | **190** |
|  | $**116** | $**163** | $**68** | $**211** |
| <u>Three Months Ended March 31, 2025</u> |  |  |  |  |
| Foreign currency purchase contracts | $54 | $— | $6 | $48 |
| Futures contracts – copper and aluminum | (156) | 780 | 53 | 571 |
|  | $(102) | $780 | $59 | $619 |

---

The change in fair value reclassified or expected to be reclassified from accumulated other comprehensive loss to earnings is summarized below. All amounts are pre-tax.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Location of Gain in Statements | Estimated to<br>be Reclassified<br>in the Next 12 Months | Three Months Ended March 31, | Three Months Ended March 31, |
|  | of Operations |  | **2026** | 2025 |
| Foreign currency purchase contracts | Depreciation and amortization | $**21** | $**6** | $6 |
| Futures contracts – copper and aluminum | Costs of products sold <br>(excluding depreciation and amortization) | $**196** | $**64** | $55 |

---

------

**<u>Note 13 – Fair Value</u>**

The Corporation's financial assets and liabilities reported at fair value in the condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Quoted Prices<br>in Active<br>Markets for<br>Identical Inputs<br>(Level 1) | Significant<br>Other<br>Observable<br>Inputs<br>(Level 2) | Significant<br>Unobservable<br>Inputs<br>(Level 3) | Total |
| **<u>As of March 31, 2026</u>** |  |  |  |  |
| **Investments** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Other noncurrent assets** | $**2597** | $**—** | $**—** | $**2597** |
| <u>As of December 31, 2025</u> |  |  |  |  |
| Investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent assets | $2802 | $— | $— | $2802 |

---

The investments held as other noncurrent assets represent assets held in the "Rabbi" trust for the purpose of providing benefits under the non-qualified defined benefit pension plan. The fair value of the investments is based on quoted prices of the investments in active markets. The fair value of futures contracts is based on market quotations. The fair values of the variable-rate IRB debt and borrowings under the revolving credit facility and other debt facilities approximate their carrying values. Additionally, the fair values of trade receivables and trade payables approximate their carrying values.

**<u>Note 14 – Stock-Based Compensation</u>**

The Ampco-Pittsburgh Corporation 2016 Omnibus Incentive Plan, as amended (the "Incentive Plan"), authorizes the issuance of up to 4,200,000 shares of the Corporation's common stock for awards under the Incentive Plan. Awards under the Incentive Plan may include incentive stock options and non-qualified stock options, stock appreciation rights, restricted shares and restricted stock units, performance awards, other stock-based awards, or short-term cash incentive awards. If any award is canceled, terminates, expires, or lapses for any reason prior to the issuance of the shares, or if the shares are issued under the Incentive Plan and thereafter are forfeited to the Corporation, the shares subject to such awards and the forfeited shares will not count against the aggregate number of shares available under the Incentive Plan. Shares tendered or withheld to pay the option exercise price or tax withholding will continue to count against the aggregate number of shares of common stock available for grant under the Incentive Plan. Any shares repurchased by the Corporation with cash proceeds from the exercise of options will not be added back to the pool of shares available for grant under the Incentive Plan.

The Incentive Plan may be administered by the Board of Directors or the Compensation Committee of the Board of Directors. The Compensation Committee has the authority to determine, within the limits of the express provisions of the Incentive Plan, the individuals to whom the awards will be granted and the nature, amount and terms of such awards.

The Incentive Plan also provides for equity-based awards during any one year to non-employee members of the Board of Directors, based on the grant date fair value, not to exceed $200. The limit does not apply to shares received by a non-employee director at his or her election in lieu of the director's retainer for board service. The restricted stock awards vest on the one-year anniversary of the grant date.

Stock-based compensation expense, including expense associated with equity-based awards granted to non-employee members of the Board of Directors, for the three months ended March 31, 2026 and 2025, equaled $292 and $306, respectively. The income tax benefit recognized in the condensed consolidated statements of operations was not significant due to the Corporation having a valuation allowance recorded against its deferred income tax assets for the majority of the jurisdictions where the expense was recognized.

------

**<u>Note 15 – Litigation</u>** 

The Corporation and its subsidiaries are involved in various claims and lawsuits incidental to their businesses from time to time and are also subject to asbestos litigation.

<u>Asbestos Litigation</u> 

Claims have been asserted alleging personal injury from exposure to asbestos-containing components historically used in some products manufactured by predecessors of Air & Liquid (the "Asbestos Liability"). Air & Liquid, and in some cases the Corporation, are defendants (among a number of defendants, often in excess of 50 defendants) in claims filed in various state and federal courts.

<u>Asbestos Claims</u> 

The following table reflects approximate information about the number of claims for the Asbestos Liability against Air & Liquid and the Corporation for the three months ended March 31, 2026 and 2025 (number of claims not in thousands). The majority of the settlement and defense costs were reported and paid by insurance carriers. Because claims are often filed and can be settled or dismissed in large groups, the amount and timing of settlements, as well as the number of open claims, can fluctuate significantly from period to period.

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Total claims pending at the beginning of the period | **5523** | 6363 |
| New claims served | **409** | 321 |
| Claims dismissed | **(24)** | (108) |
| Claims settled | **(84)** | (171) |
| Total claims pending at the end of period <sup>(1)</sup> | **5824** | 6405 |
| Administrative closures <sup>(2)</sup> | **(2926)** | (3320) |
| Total active claims at the end of the period | **2898** | 3085 |
| Gross settlement and defense costs paid in period (in 000's) | $**5363** | $6775 |
| Average gross settlement and defense costs per claim resolved (in 000's) <sup>(3)</sup> | $**49.66** | $24.28 |

---

*(1) Included as "total claims pending" are approximately 1,641 and 1,637 claims at March 31, 2026 and 2025, respectively, classified in various jurisdictions as "inactive" or transferred to a state or federal judicial panel on multi-district litigation.* 

*(2) Administrative closures include (i) mesothelioma claims filed* five *or more years ago; (ii) non-mesothelioma claims filed* six *or more years ago; (iii) claims previously classified in various jurisdictions as "inactive;" and (iv) claims transferred to a state or federal judicial panel on multi-district litigation.* 

*(3) Claims resolved do not include claims administratively closed.*

<u>Asbestos Insurance</u> 

The Corporation and Air & Liquid are parties to a series of settlement agreements ("Settlement Agreements") with insurance carriers that have coverage obligations for the Asbestos Liability (the "Settling Insurers"). Under the Settlement Agreements, the Settling Insurers accept financial responsibility, subject to the terms and conditions of the respective agreements, including overall coverage limits, for pending and future claims for the Asbestos Liability. The Settlement Agreements encompass the majority of insurance policies that provide coverage for claims associated with the Asbestos Liability.

The Settlement Agreements acknowledge Howden North America, Inc. ("Howden") is entitled to coverage under policies covering the Asbestos Liability for claims arising out of the historical products manufactured or distributed by Buffalo Forge, a former subsidiary of the Corporation (the "Products"), which was acquired by Howden. The Settlement Agreements do not provide for any prioritization on access to the applicable policies or any sub-limits of liability as to Howden or the Corporation and Air & Liquid and, accordingly, Howden may access the coverage afforded by the Settling Insurers for any covered claim arising out of the Products. In general, access by Howden to the coverage afforded by the Settling Insurers for the Products will erode coverage under the Settlement Agreements available to the Corporation and Air & Liquid for the Asbestos Liability.

<u>Asbestos Valuations</u> 

The Corporation, with the assistance of a nationally recognized expert in the valuation of asbestos liabilities, reviews the Asbestos Liability and the underlying assumptions on a regular basis to determine whether any adjustments to the Asbestos Liability or the underlying assumptions are necessary. When warranted, the Asbestos Liability is adjusted to consider current trends and new information that becomes available. In conjunction with the regular updates of the estimated Asbestos Liability, the Corporation also develops an estimate of defense costs expected to be incurred with settling the Asbestos Liability, probable insurance recoveries for the Asbestos Liability and defense costs.

------

In developing the estimate of probable defense costs, the Corporation considers several factors including, but not limited to, current and historical defense-to-indemnity cost ratios and expected defense-to-indemnity cost ratios. In developing the estimate of probable insurance recoveries, the Corporation considers the expert's projection of settlement costs for the Asbestos Liability and management's projection of associated defense costs. In addition, the Corporation consults with its outside legal counsel on insurance matters and a nationally recognized insurance consulting firm it retains to assist with certain policy allocation matters. The Corporation also considers a number of other factors including the Settlement Agreements in effect, policy exclusions, policy limits, policy provisions regarding coverage for defense costs, attachment points, gaps in the coverage, policy exhaustion, the nature of the underlying claims for the Asbestos Liability, estimated erosion of insurance limits on account of claims against Howden arising out of the Products, prior impairment of policies, insolvencies among certain of the insurance carriers, and creditworthiness of the remaining insurance carriers based on publicly available information. Based on these factors, the Corporation estimates the probable insurance recoveries for the Asbestos Liability and defense costs for the corresponding time frame of the Asbestos Liability.

The following table summarizes activity relating to the Asbestos Liability for the three months ended March 31, 2026 and 2025.

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Asbestos liability, beginning of the year | $**198332** | $207092 |
| Settlement and defense costs paid | **(5363)** | (6775) |
| Asbestos liability, end of the period | $**192969** | $200317 |

---

The following table summarizes activity relating to insurance recoveries for the three months ended March 31, 2026 and 2025.

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Insurance receivable – asbestos, beginning of the year | $**126838** | $139295 |
| Settlement and defense costs paid by insurance carriers | **(4267)** | (4408) |
| Insurance receivable – asbestos, end of the period | $**122571** | $134887 |

---

The insurance receivable does not assume any recovery from insolvent carriers. A substantial majority of the insurance recoveries deemed probable is from insurance companies rated A – (excellent) or better by A.M. Best Corporation. There can be no assurance, however, there will not be insolvencies among the relevant insurance carriers, or the assumed percentage recoveries for certain carriers will prove correct.

<u>Asbestos Assumptions</u>

The amounts recorded for the Asbestos Liability and insurance receivable rely on assumptions based on currently known facts and strategy. The Corporation's actual expenses or insurance recoveries could be significantly higher or lower than those recorded if assumptions used in the Corporation's or the experts' calculations vary significantly from actual results. Key variables in these assumptions include the forecast of the population likely to have been exposed to asbestos; the number of people likely to develop an asbestos-related disease; the estimated number of people likely to file an asbestos-related injury claim against the Corporation or its subsidiaries; an analysis of pending cases, by type of injury claimed and jurisdiction where the claim is filed; average settlement value of claims, by type of injury claimed and jurisdiction of filing; the number and nature of new claims to be filed each year; the average cost of disposing of each new claim; the average annual defense costs; compliance by relevant parties with the terms of the Settlement Agreements; ability to reach acceptable agreements with insurance carriers currently not a party to a Settlement Agreement or at a coverage amount less than anticipated; and the solvency risk with respect to the relevant insurance carriers. Other factors that may affect the Asbestos Liability and ability to recover under the Corporation's insurance policies include uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, reforms that may be made by state and federal courts, and the passage of state or federal tort reform legislation.

The Corporation intends to continue to evaluate the Asbestos Liability, related insurance receivable, the sufficiency of its allowance for expected credit losses and the underlying assumptions on a regular basis to determine whether any adjustments to the estimates are required. Due to the uncertainties surrounding asbestos litigation and insurance recovery, these regular reviews may result in the Corporation adjusting its current reserve; however, the Corporation is currently unable to estimate such future adjustments. Adjustments, if any, to the Corporation's estimate of the Asbestos Liability, insurance receivable and/or allowance for expected credit losses could be material to the operating results for the period in which the adjustments to the liability, receivable or allowance are recorded and to the Corporation's condensed consolidated financial position, results of operations and liquidity.

------

**<u>Note 16 – Environmental Matters</u>** 

The Corporation is currently performing certain remedial actions in connection with the sale of real estate previously owned and periodically incurs costs to maintain compliance with environmental laws and regulations. Environmental exposures are difficult to assess and estimate for numerous reasons, including lack of reliable data, the multiplicity of possible solutions, the years of remedial and monitoring activity required, and identification of new sites. The undiscounted potential liability for remedial actions and environmental compliance measures approximated $100 at March 31, 2026 and December 31, 2025.

**<u>Note 17 – Related Parties</u>** 

Åkers TISCO Roll Co., Ltd. ("ATR"), a 59.88% indirectly owned joint venture of UES, has sales to and purchases from ATR's minority shareholder and its affiliates and sales to a shareholder of one of the Corporation's other joint ventures in China and its affiliates. These sales and purchases, which were in the ordinary course of business, for the three months ended March 31, 2026 and 2025 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | **2026** | 2025 | 2025 |
|  | **USD** | **RMB** | USD | RMB |
| Purchases from related parties | $**2487** | **17232** | $2076 | 15089 |
| Sales to related parties | $**5196** | **36001** | $5039 | 36621 |

---

Purchases from related parties are included in costs of products sold (excluding depreciation and amortization) and selling and administrative on the condensed consolidated statements of operations or inventories on the condensed consolidated balance sheet.

Balances outstanding with ATR's minority shareholder including its affiliates and the other joint venture's shareholder and its affiliates as of March 31, 2026 and December 31, 2025 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | December 31, 2025 | December 31, 2025 |
|  | **USD** | **RMB** | USD | RMB |
| Accounts receivable from related parties | $**2597** | **17766** | $2390 | 16723 |
| Accounts payable to related parties | $**636** | **4394** | $69 | 481 |

---

The manufacturing facilities of ATR are located on land leased by ATR from the other partner. The land lease commenced in 2007, the date the joint venture was formed, and continues through 2054, the expected end date of the joint venture, and includes variable lease payments based on the land standard price prevailing in Taiyuan, China, where the joint venture is located. Rent paid by ATR to the other partner approximated $31 (RMB 223) for each of the three months ended March 31, 2026 and 2025, which is included in purchases from related parties.

For the three months ended March 31, 2026, the Corporation had purchases from UES-UK to fulfill orders on existing customer contracts. These purchases, which were in the ordinary course of business, for the three months ended March 31, 2026, were as follows:

---

| | |
|:---|:---|
|  | **Three Months Ended March 31, 2026** |
| Purchases from UES-UK | $**1723** |

---

Purchases from UES-UK are included in costs of products sold (excluding depreciation and amortization) on the condensed consolidated statement of operations for the three months ended March 31, 2026.

Balances outstanding with UES-UK were as follows:

---

| | | |
|:---|:---|:---|
|  | **March 31,<br>2026** | December 31,<br>2025 |
| Accounts payable to UES-UK | $**137** | $**1758** |

---

**<u>Note 18 – Business Segments</u>**

The FCEP segment produces forged hardened steel rolls, cast rolls and forged engineered products ("FEP"). Forged hardened steel rolls are used primarily in hot and cold rolling mills by producers of steel, aluminum and other metals. Cast rolls, which are produced

------

in a variety of iron and steel qualities, are used mainly in hot strip mills, medium/heavy section mills, roughing mills, and plate mills. FEP principally are sold to customers in the steel distribution market, oil and gas industry and aluminum and plastic extrusion industries. The segment has operations in the United States, Sweden, Slovenia, and equity interests in two joint venture companies in China. Collectively, the segment primarily competes with European, Asian and North American and South American companies in both domestic and foreign markets and distributes a significant portion of its products through sales offices located throughout the world.

The ALP segment includes Aerofin, Buffalo Air Handling and Buffalo Pumps, all divisions of Air & Liquid. Aerofin produces custom-engineered finned tube heat exchange coils and related heat transfer products for a variety of industries including original equipment manufacturers and commercial, nuclear power generation and industrial manufacturing. Buffalo Air Handling produces large custom-designed air handling systems for institutional (e.g., hospital, university), pharmaceutical and general industrial building markets. Buffalo Pumps manufactures centrifugal pumps for the fossil-fueled power generation, marine defense and industrial refrigeration industries. The segment has operations in Virginia and New York with headquarters in Carnegie, Pennsylvania. The segment utilizes an independent group of sales offices located throughout the United States and Canada.

Net sales by product line for the three months ended March 31, 2026 and 2025 are outlined below.

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Net sales: |  |  |
| &nbsp;&nbsp;Forged and Cast Engineered Products |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forged and cast mill rolls | $**66368** | $68622 |
| &nbsp;&nbsp;&nbsp;&nbsp;FEP | **4441** | 3665 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forged and Cast Engineered Products | **70809** | 72287 |
| &nbsp;&nbsp;Air and Liquid Processing |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Air handling systems | **13043** | 10628 |
| &nbsp;&nbsp;&nbsp;&nbsp;Heat exchange coils | **13068** | 11525 |
| &nbsp;&nbsp;&nbsp;&nbsp;Centrifugal pumps | **11407** | 9825 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Air and Liquid Processing | **37518** | 31978 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Reportable Segments | $**108327** | $104265 |

---

The accounting policies for each segment are the same as those described in Item 8, *Financial Statements and Supplementary Data*, in Part II of the Corporation's Annual Report on Form 10-K for the year ended December 31, 2025. The Corporation's Chief Executive Officer is the Corporation's CODM.

The Corporation measures each segment's profitability based on income from operations, which excludes interest expense, other income and expense items and Corporate costs. Along with other measures, the CODM uses segment income from operations when assessing segment performance and when making decisions to allocate financial resources between segments, primarily through periodic budgeting and segment performance reviews.

Summarized financial information for the Corporation's reportable segments is shown in the following tables.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | **2026** | **2026** | 2025 | 2025 | 2025 |
|  | **FCEP** | **ALP** | **Total** | FCEP | ALP | Total |
| Net sales | $**70809** | $**37518** | $**108327** | $72287 | $31978 | $104265 |
| Less:<sup>(1)</sup> |  |  |  |  |  |  |
| &nbsp;&nbsp;Cost of products sold (excluding depreciation and amortization) | **59191** | **27564** |  | 57613 | 24491 |  |
| &nbsp;&nbsp;Selling and administrative | **5920** | **4235** |  | 6385 | 3725 |  |
| &nbsp;&nbsp;Depreciation and amortization | **3924** | **327** |  | 4368 | 268 |  |
| &nbsp;&nbsp;(Gain) loss on disposal of assets | **(7)** |  |  | 16 |  |  |
| &nbsp;&nbsp;Deconsolidation Charge<sup>(2)</sup> | **875** |  |  |  |  |  |
| Segment income from operations | $**906** | $**5392** | $**6298** | $3905 | $3494 | $7399 |
| *Reconciliation to income before income taxes* |  |  |  |  |  |  |
| Corporate costs <sup>(3)</sup> |  |  | **(3736)** |  |  | (3549) |
| Interest expense |  |  | **(2723)** |  |  | (2726) |
| Other income - net <sup>(4)</sup> |  |  | **596** |  |  | 826 |
| Income before income taxes |  |  | $**435** |  |  | $1950 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(1) The significant expense categories and amounts align with the segment-level information regularly provided to the CODM.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(2) Deconsolidation Charge represents the write-down of the Estimated Recovery associated with the UES-UK insolvency.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(3) Corporate costs represent the operating expenses of the corporate office and other costs not allocated to the segments.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(4) Other income - net includes net pension and other postretirement income, gains on foreign exchange transactions, unrealized losses on Rabbi trust investments, and investment income.*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Capital Expenditures** | **Capital Expenditures** | **Depreciation and<br>Amortization Expense** | **Depreciation and<br>Amortization Expense** | **Identifiable Assets**<sup>(1)</sup> | **Identifiable Assets**<sup>(1)</sup> |
|  | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | **March 31,** | December 31, |
|  | **2026** | 2025 | **2026** | 2025 | **2026** | 2025 |
| FCEP | $**1122** | $1399 | $**3924** | $4368 | $**274084** | $272303 |
| ALP | **2263** | 801 | **327** | 268 | **215887** | 215833 |
| Corporate | **—** |  | **7** |  | **7236** | 7219 |
| Consolidated total | $**3385** | $2200 | $**4258** | $4636 | $**497207** | $495355 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Long-lived Assets**<sup>(2)</sup> | **Long-lived Assets**<sup>(2)</sup> | **Net Sales by <br>Geographic Area**<sup>(3)</sup> | **Net Sales by <br>Geographic Area**<sup>(3)</sup> | **Income<br>Before Income Taxes**<sup>(4)</sup> | **Income<br>Before Income Taxes**<sup>(4)</sup> |
|  | **March 31,** | December 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| **Geographic Areas:** | **2026** | 2025 | **2026** | 2025 | **2026** | 2025 |
| United States | $**206016** | $211461 | $**70429** | $59896 | $**(2023)** | $397 |
| Foreign | **38233** | 40376 | **37898** | 44369 | **2458** | 1553 |
| Consolidated total | $**244249** | $251837 | $**108327** | $104265 | $**435** | $1950 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(1) Identifiable assets for the FCEP segment include (i) the Estimated Recovery of $5,370 at March 31, 2026 and $7,500 at December 31, 2025 and (ii) investments in joint ventures of $835 at each of March 31, 2026 and December 31, 2025. Identifiable assets for the ALP segment include asbestos-related insurance receivables of $122,571 and $126,838 at March 31, 2026 and December 31, 2025, respectively. Identifiable assets for Corporate represent cash and cash equivalents and other items not allocated to reportable segments.* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(2) Long-lived assets exclude deferred income tax assets. Long-lived assets in the U.S. include noncurrent asbestos-related insurance receivables of $103,571 and $107,838 at March 31, 2026 and December 31, 2025, respectively. Foreign long-lived assets primarily represent assets of the foreign operations.* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(3) Net sales are attributed to the geographic areas based on the location of the customer. Sales to individual foreign countries were less than 10% of condensed consolidated net sales for each of the periods. The majority of foreign net sales for each of the periods is attributable to the FCEP segment.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(4) Income before income taxes for the United States for the three months ended March 31, 2026 includes the Deconsolidation Charge of $875.*

------

**<u>ITEM 2 – MANAGEMENT'S DI</u><u>SCUSSION AND ANALYSIS OF</u>** 

**<u>FINANCIAL CONDITION AND RESULTS OF OPERATIONS</u>** 

*(in thousands, except per share amounts)* 

**<u>Forward-Looking Statements</u>** 

The Private Securities Litigation Reform Act of 1995 (the "Act") provides a safe harbor for forward-looking statements made by us or on behalf of Ampco-Pittsburgh Corporation and its subsidiaries (collectively, "we," "us," "our," or the "Corporation"). *Management's Discussion and Analysis of Financial Condition and Results of Operations* and other sections of this Quarterly Report on Form 10-Q, as well as the condensed consolidated financial statements and notes hereto, may include, but are not limited to, statements about operating performance, trends and events we expect or anticipate will occur in the future, statements about sales and production levels, timing of orders for our products, restructurings, the impact from pandemics and geopolitical conflicts, profitability and anticipated expenses, inflation, the global supply chain, the continued impact of tariffs, global trade conditions, and cash outflows. All statements in this document other than statements of historical fact are statements that are, or could be, deemed "forward-looking statements" within the meaning of the Act and words such as "may," "will," "intend," "believe," "expect," "anticipate," "estimate," "project," "target," "goal," "forecast," and other terms of similar meaning that indicate future events and trends are also generally intended to identify forward-looking statements. Forward-looking statements speak only as of the date on which such statements are made, are not guarantees of future performance or expectations, and involve risks and uncertainties. For us, these risks and uncertainties include, but are not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•inability to maintain adequate liquidity to meet our operating cash flow requirements, debt service costs, net asbestos payments, and other financial obligations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•cyclical demand for our products, economic downturns and insufficient demand for our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•excess global capacity in the steel industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•inability to successfully restructure our operations, complete internal reorganizations, scale our operations, and/or invest in operations that will yield optimal long-term value to our shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•inability to obtain necessary capital or financing on satisfactory terms to acquire capital expenditures that may be necessary to support our growth strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•liability of our subsidiaries for claims alleging personal injury from exposure to asbestos-containing components historically used in certain products of our subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•limitations in availability of capital to fund our strategic plans or at acceptable interest rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•fluctuations in the value of the U.S. dollar and the functional (local) currency of our subsidiaries relative to other currencies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•changes in the global economic environment, inflation, the ongoing impact of tariffs, elevated interest rates, recessions or prolonged periods of slow economic growth, global instability, consequences of pandemics, and actual and threatened geopolitical conflict;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•increases in commodity prices or insufficient hedging against increases in commodity prices, reductions in electricity and natural gas supply, or shortages of key production materials for us or our customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•inability to maintain compliance with the covenants, representations, or warranties of our various debt agreements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•inoperability of certain equipment on which we rely;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•work stoppage or another industrial action on the part of any of our unions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•changes in the existing regulatory environment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•inability to satisfy the continued listing requirements of the New York Stock Exchange;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•failure to maintain an effective system of internal control;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•potential attacks on information technology infrastructure and other cyber-based business disruptions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•those discussed more fully elsewhere in this report and in documents filed with the Securities and Exchange Commission by us, particularly in Item 1A, Risk Factors, in Part I of our Annual Report on Form 10-K for the year ended December 31, 2025.

Additionally, as it relates to the insolvency proceedings of Union Electric Steel UK Limited ("UES-UK"), an indirect wholly owned subsidiary of the Corporation, any forward-looking statements are subject to risks and uncertainties related to such proceedings,

------

including but not limited to: the actions of the certain insolvency practitioners of FRP Advisory Trading Limited ("FRP") as administrators of UES-UK (collectively, the "Administrators") and the High Court of Justice, Business and Property Courts at Leeds (the "Insolvency Court"); the interpretation and application of U.K. insolvency law; potential claims by creditors or other stakeholders; the ability to recover assets; the rights of purported secured creditors to satisfy their claims and reduce our obligations to them; and the broader impact on the Corporation's condensed consolidated financial condition, results of operations, and strategic plans.

We cannot guarantee any future results, levels of activity, performance or achievements. In addition, there may be events in the future that we are not able to predict accurately or control which may cause actual results to differ materially from expectations expressed or implied by forward-looking statements. Except as required by applicable law, we assume no obligation, and disclaim any obligation, to update forward-looking statements whether as a result of new information, events or otherwise.

**<u>The Business</u>**

The Corporation manufactures and sells highly engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments – the *Forged and Cast Engineered Products* ("FCEP") segment and the *Air and Liquid Processing* ("ALP") segment. This segment presentation is consistent with how the Corporation's chief operating decision-maker evaluates financial performance and makes resource allocation and strategic decisions about the business.

The FCEP segment produces forged hardened steel rolls, cast rolls and forged engineered products ("FEP"). Forged hardened steel rolls are used primarily in hot and cold rolling mills by producers of steel, aluminum and other metals. Cast rolls, which are produced in a variety of iron and steel qualities, are used mainly in hot strip mills, medium/heavy section mills, roughing mills, and plate mills. FEP principally are sold to customers in the steel distribution market, oil and gas industry and aluminum and plastic extrusion industries. The segment has operations in the United States, Sweden, Slovenia, and an equity interest in two joint venture companies in China. Collectively, the segment primarily competes with European, Asian and North and South American companies in both domestic and foreign markets and distributes a significant portion of its products through sales offices located throughout the world.

The ALP segment includes Aerofin, Buffalo Air Handling and Buffalo Pumps, all divisions of Air & Liquid Systems Corporation ("Air & Liquid"), a wholly owned subsidiary of the Corporation. Aerofin produces custom-engineered finned tube heat exchange coils and related heat transfer products for a variety of industries including original equipment manufacturers ("OEM") and commercial, nuclear power generation and industrial manufacturing. Buffalo Air Handling produces large custom-designed air handling systems for institutional (e.g., hospital, university), pharmaceutical and general industrial building markets. Buffalo Pumps manufactures centrifugal pumps for the fossil-fueled power generation, marine defense and industrial refrigeration industries. The segment has operations in Virginia and New York with headquarters in Carnegie, Pennsylvania. The segment utilizes an independent group of sales offices located throughout the United States and Canada.

**<u>UES-UK and AUP</u>**

On October 14, 2025, (the "Filing Date"), the Directors of UES-UK filed a Notice of Appointment with the High Court of Justice, Business and Property Courts at Leeds formally appointing FRP as Administrators of UES-UK. This action was confined to UES-UK exclusively and did not affect the Corporation or any of its other subsidiaries. As of the Filing Date, UES-UK was in administration and its affairs, business and property were being managed by the Administrators (the "Structured Insolvency").

Through October 13, 2025, the date immediately prior to the Filing Date, the operating results of UES-UK are included in the condensed consolidated operating results of the Corporation. Effective as of the Filing Date, the Corporation no longer consolidates the operating results of UES-UK, as the Corporation no longer has decision-making control over UES-UK. As of the Filing Date, the Corporation (i) wrote down its investment in UES-UK to its estimated fair value; (ii) recognized the other comprehensive losses of UES-UK deferred in accumulated other comprehensive loss; and (iii) established an estimated recovery for the amount of funds expected to be returned to the lenders under the Corporation's Second Amended and Restated Revolving Credit, Term Loan and Security Agreement (the "Credit Agreement"), if any, after the costs and expenses of the Structured Insolvency, since the accounts receivables, inventories, and equipment of UES-UK were held as collateral under the Credit Agreement (the "Estimated Recovery").

The Estimated Recovery recorded and outstanding as of December 31, 2025 equaled $7,500, which was based on the Corporation's assessment of the expected recovery from the insolvency proceedings, including consideration of information provided by the Administrators such as the value and the priority of the claims by various creditors. In January 2026, the Administrators distributed $1,255, which was returned to the lenders under the Credit Agreement and reduced the Corporation's balance outstanding under the Credit Agreement. As of March 31, 2026, the Corporation evaluated the collectability of the remaining Estimated Recovery and, based on updated information received from the Administrators including lower funds expected to be available for future distributions, wrote down the Estimated Recovery by $875 which is recognized as a Deconsolidation Charge in the accompanying condensed consolidated statement of operations.

------

The Corporation will continue to evaluate the collectability of the Estimated Recovery and will adjust the Estimated Recovery based on facts and circumstances at each reporting date. If it is determined the Estimated Recovery is expected to be lower than currently estimated, then the Estimated Recovery would be reduced and a charge to net (loss) income would be recorded. Similarly, if it is determined the Estimated Recovery is expected to be higher than currently estimated, then the Estimated Recovery would be increased and a credit to net (loss) income would be recorded. Any recovery will be distributed in the order of priority set forth in the Insolvency Act 1986.

In addition, during 2025, the Corporation closed its non-core steel distribution facility located in Ohio previously held by Alloys Unlimited and Processing, LLC ("AUP"). In December 2025, AUP was merged into Union Electric Steel Corporation, a direct wholly owned subsidiary of the Corporation.

**<u>Executive Overview</u>**

For the FCEP segment, global steel manufacturing capacity continues to exceed global steel product consumption. Steel demand is soft but, to date, has been improving for the segment's largest markets. In the third quarter of 2025, the U.S. government announced new tariffs on coated steel imports and, effective April 2026, tariffs were increased to 50% on most flat-rolled steel imported into the United States. These additional tariff protections cover more products for our North American customers and have meaningfully reduced imports, thereby supporting pricing, improving U.S. steel mill utilization and, in turn, increasing the number of rolling mill rolls being consumed, a positive for the segment.

Tariffs are now applied to steel forged and cast rolls shipped from the segment's European facilities to the United States and to U.S. forged and cast rolls shipped to China. Steel is an important distinction as the highest volume of cast rolls imported into the United States is subject only to a country-specific tariff of 10%, which will expire in the third quarter of 2026, instead of the higher rates on steel forged roll imports. As the U.S. market is underserved for cast rolls, these tariffs have had little effect on our business. Tariffs remain in place for products that compete with our FEP products, resulting in increases in orders and higher margins.

Following the closure of its U.K. facility, the primary focus for the FCEP segment is to optimize its facility in Sweden, including increasing production levels and improving product mix by eliminating certain lower-margin orders. In addition, the segment aims to improve its profitability by maintaining a strong position in the Western roll market and continuing to improve operational efficiency.

For the ALP segment, businesses are benefiting from increased demand across the power generation and defense sectors. By prioritizing customer relationships and delivering highly engineered solutions, we believe the segment has successfully increased market share and is actively investing in increased capacity to support this growth. Though it continues to face rising production costs due to inflation, the segment has mitigated these effects through strategic price increases. The focus for this segment is to grow revenues, strengthen engineering and manufacturing capabilities and continue to improve its sales distribution network.

The Corporation is actively monitoring, and will continue to actively monitor, changes prompted by the U.S. government, repercussions from the ongoing Middle East conflicts and similar geopolitical matters, economic conditions, and other developments relevant to its business including the potential impact on its operations, financial condition, liquidity, suppliers, industry, and workforce.

------

**<u>Selected Financial Information</u>**

---

| | | | |
|:---|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 | Change |
| Net Sales: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;FCEP | $**70809** | $72287 | $(1478) |
| &nbsp;&nbsp;&nbsp;&nbsp;ALP | **37518** | 31978 | 5540 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | $**108327** | $104265 | $4062 |
| Income from Operations: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;FCEP | $**906** | $3905 | $(2999) |
| &nbsp;&nbsp;&nbsp;&nbsp;ALP | **5392** | 3494 | 1898 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate costs | **(3736)** | (3549) | (187) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | $**2562** | $3850 | $(1288) |
|  | **March 31,<br>2026** | December 31,<br>2025 | Change |
| Backlog: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;FCEP | $**201741** | $208604 | $(6863) |
| &nbsp;&nbsp;&nbsp;&nbsp;ALP | **143791** | 120333 | 23458 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | $**345532** | $328937 | $16595 |

---

<u>Net sales</u> approximated $108,327 and $104,265 for the three months ended March 31, 2026 and 2025, respectively, an improvement of $4,062. A discussion of net sales for the Corporation's two segments is included below.

<u>Income from operations</u> approximated $2,562 and $3,850 for the three months ended March 31, 2026 and 2025, respectively, a decrease of $1,288. Income from operations for the three months ended March 31, 2026 includes the Deconsolidation Charge of $875 associated with the write-down of the Estimated Recovery. A discussion of income from operations for the Corporation's two segments is included below.

Backlog equaled $345,532 as of March 31, 2026 versus $328,937 as of December 31, 2025. Backlog represents the accumulation of firm orders on hand which: (i) are supported by evidence of a contractual arrangement, (ii) include a fixed and determinable sales price, (iii) have reasonably assured collectability, and (iv) generally are expected to ship within two years from the backlog reporting date. Backlog at a certain date may not be a direct measure of future revenue for a particular order because price increases, negotiated subsequently to the original order, are not included in backlog until the updated contract is received from the customer, certain surcharges are not determinable until the order is complete and ready for shipment to the customer, and certain orders are denominated in currency other than the functional (local) currency of the subsidiary and are not hedged. Approximately 18% of the backlog is expected to be released after 2026. A discussion of backlog by segment is included below.

<u>Costs of products sold, excluding depreciation and amortization</u>, as a percentage of net sales, for the three months ended March 31, 2026 and 2025 approximated 80.1% and 78.7% respectively, with the increase primarily being driven by the FCEP segment. See further discussion in the below commentary for the Corporation's two segments.

<u>Selling and administrative expenses</u> approximated $13,884 and $13,659 for the three months ended March 31, 2026 and 2025, respectively, an increase of $225. Closure of UES-UK and AUP in the fourth quarter of 2025 eliminated approximately $970 of selling and administrative costs for the three months ended March 31, 2026 when compared to the three months ended March 31, 2025 offset by higher commissions for the ALP segment of approximately $600, higher employee-related costs, and general inflationary increases.

<u>Depreciation and amortization</u> approximated $4,258 and $4,636 for the three months ended March 31, 2026 and 2025, respectively, a decrease of $378 principally attributable to the absence of depreciation for UES-UK and AUP for the three months ended March 31, 2026 when compared to the three months ended March 31, 2025.

<u>Interest expense</u> was comparable for the three months ended March 31, 2026 and 2025, primarily due to:

------

---

| | |
|:---|:---|
|  | **Three Months Ended March 31, 2026** |
| Lower average borrowings outstanding | $**(103)** |
| Lower average interest rates - primarily revolving credit facility | **(94)** |
| Interest on Equipment Term Notes | **175** |
| Other | **19** |
|  | $**(3)** |

---

<u>Other income – net</u> is comprised of the following:

---

| | | | |
|:---|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 | Change |
| Net pension and other postretirement income | $**435** | $665 | $(230) |
| Gains on foreign exchange transactions, net | **205** | 221 | (16) |
| Investment income | **19** | 24 | (5) |
| Unrealized losses on Rabbi trust investments | **(63)** | (89) | 26 |
| Other | **—** | 5 | (5) |
|  | $**596** | $826 | $(230) |

---

Other income – net fluctuated primarily due to lower net pension and other postretirement income, which is principally attributable to the U.S. defined benefit pension plan reaching a fully funded status in early 2026, resulting in a change in its investment strategies to a more conservative portfolio.

<u>Income tax provision</u> for each of the periods includes income taxes associated with the Corporation's profitable operations. An income tax benefit is not able to be recognized on losses of certain of the Corporation's entities since it is "more likely than not" the asset will not be realized. Accordingly, changes in the income tax provision for each of the periods include the effects of changes in the pre-tax income of the Corporation's profitable operations in each jurisdiction and changes in expectations as to whether an income tax benefit will be able to be realized for the deferred income tax assets recognized.

The income tax provisions for three months ended March 31, 2025 includes a one-time income tax benefit of approximately $500, resulting from the Corporation's majority-owned Chinese joint venture initially qualifying as a high-tech enterprise ("HTE"). As a HTE, the earnings of the Chinese joint venture through the end of 2026 will be taxed at a rate of 15% (versus 25%). The HTE status is renewable, subject to certain criteria being met, for which the Chinese joint venture expects to renew.

Valuation allowances are recorded against the majority of the Corporation's deferred income tax assets. The Corporation will maintain the valuation allowances until there is sufficient evidence to support the reversal of all or some portion of the allowances. Given the Corporation's current earnings and anticipated future earnings in Sweden and in the United States, the Corporation believes there is a reasonable possibility within the next 12 months, sufficient positive evidence may become available to allow the Corporation to conclude some portion of the valuation allowance will no longer be needed. Release of any portion of the valuation allowance would result in the recognition of deferred income tax assets on the Corporation's condensed consolidated balance sheet and a decrease to the Corporation's income tax expense in the period the release is recorded. The exact timing and the amount of the valuation allowance released are subject to, among many items, the level of profitability achieved. Once the valuation allowance is completely reversed, a tax provision would be recognized on future earnings.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was enacted in the United States. OBBBA introduces multiple tax law and legislative changes. The Corporation has recognized the effects of the OBBBA provisions in its condensed consolidated financial statements to the extent they are applicable. Certain provisions of the OBBBA have effective dates after the date of this Quarterly Report on Form 10-Q; accordingly, the Corporation will continue to evaluate the impact of these provisions on its future condensed consolidated financial statements.

<u>Net loss attributable to Ampco-Pittsburgh and net loss per common share attributable to Ampco-Pittsburgh</u> equaled $(867), or $(0.04) per common share for the three months ended March 31, 2026 and included the Deconsolidation Charge, which increased the net loss attributable to Ampco-Pittsburgh and net loss per common share attributable to Ampco-Pittsburgh by $875 and $0.04 per common share for the three months ended March 31, 2026.

Net income attributable to Ampco-Pittsburgh and net income per common share attributable to Ampco-Pittsburgh for the three months ended March 31, 2025 equaled $1,142, or $0.06 per common share and included the income tax benefit resulting from the Corporation's majority-owned Chinese joint venture qualifying as an HTE of approximately $500, which improved net income attributable to Ampco-Pittsburgh and net income per common share attributable to Ampco-Pittsburgh by approximately $299 and $0.01 per common share for the three months ended March 31, 2025.

------

**<u>Net Sales and Operating Results by Segment</u>**

<u>Forged and Cast Engineered Products</u>

---

| | | | |
|:---|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 | Change |
| Net Sales: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forged and cast mill rolls | $**66368** | $68622 | $(2254) |
| &nbsp;&nbsp;&nbsp;&nbsp;FEP | **4441** | 3665 | 776 |
|  | $**70809** | $72287 | $(1478) |
| Income from Operations | $**906** | $3905 | $(2999) |
|  | **March 31,<br>2026** | December 31,<br>2025 | Change |
| Backlog | $**201741** | $208604 | $(6863) |

---

Net sales for the three months ended March 31, 2026 decreased $1,478 when compared to the same period of the prior year primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Lower volume of roll shipments primarily due to timing which decreased net sales by approximately $4,600; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Lower volume of FEP shipments which decreased net sales by approximately $800; offset by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Changes in exchange rates used to translate net sales of the segment's foreign subsidiaries into the U.S. dollar which increased net sales by approximately $3,700; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher variable-index surcharges passed through to customers as a result of fluctuations in the price of raw materials, energy and transportation costs, offset by slightly lower pricing due to changes in product mix which increased net sales by approximately $200.

Income from operations for the three months ended March 31, 2026 decreased by $2,999 when compared to the three months ended March 31, 2025 primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Unfavorable manufacturing absorption which adversely impacted operating results by approximately $2,400;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Lower volume of roll and FEP shipments, primarily due to timing, and unfavorable product mix which decreased operating results by approximately $1,500; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The Deconsolidation Charge of $875; offset by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Lower manufacturing costs and higher variable-index surcharges net of slightly lower pricing, which increased operating results by approximately $900;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Lower selling and administrative costs principally due to the closures of UES-UK and AUP offset by higher employee-related costs and general inflation, which increased operating income by approximately $500; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Changes in exchange rates used to translate the operating results of the segment's foreign subsidiaries into the U.S. dollar which improved operating results by approximately $400.

Backlog decreased at March 31, 2026 from December 31, 2025 by $6,863 primarily due to timing with customer orders for 2027 expected later in 2026. Additionally, lower exchange rates used to translate the backlog of the Corporation's foreign subsidiaries into

------

the U.S. dollar decreased backlog at March 31, 2026, when compared to backlog at December 31, 2025, by approximately $2,600. At March 31, 2026, approximately 11% of the segment's backlog is expected to ship after 2026.

<u>Air and Liquid Processing</u>

---

| | | | |
|:---|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 | Change |
| Net Sales: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Air handling systems | $**13043** | $10628 | $2415 |
| &nbsp;&nbsp;&nbsp;&nbsp;Heat exchange coils | **13068** | 11525 | 1543 |
| &nbsp;&nbsp;&nbsp;&nbsp;Centrifugal pumps | **11407** | 9825 | 1582 |
|  | $**37518** | $31978 | $5540 |
| Income from Operations | $**5392** | $3494 | $1898 |
|  | **March 31,<br>2026** | December 31,<br>2025 | Change |
| Backlog | $**143791** | $120333 | $23458 |

---

The increase in net sales for the three months ended March 31, 2026, when compared to the same period of the prior year, is primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher net sales of air handling units principally due to increased demand.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher net sales of heat exchange coils principally due to:

oHigher volume of shipments of commercial OEM product, which increased net sales by approximately $2,070; and

oHigher volume of shipments to customers in the power generation market, which increased nets sales by approximately $850; offset by

oLower volume of shipments to industrial OEMs, which reduced net sales by approximately $1,380.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher net sales of centrifugal pumps principally due to:

oHigher volume of shipments of pumps and aftermarket products to customers in the power generation market, which is benefiting from increased demand due to the growth in the data center market, which increased net sales by approximately $2,120; and

oHigher volume of shipments of aftermarket orders to the U.S. Navy market primarily due to increased demand, which increased nets sales by approximately $540; offset by

oLower volume of shipments of new pump sets to the U.S. Navy market principally due to timing of orders as requested by customers, which decreased net sales by approximately $1,080.

The improvement in operating income for the three months ended March 31, 2026, when compared to the three months ended March 31, 2025, is principally due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher volume of net sales and changes in product mix, which benefited operating income by approximately $2,500; offset by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher commission costs of approximately $600, due to the increase in commissionable sales of air handling units.

Backlog at March 31, 2026 improved when compared to backlog at December 31, 2025 by approximately $23,458 with each of the product lines improving. In particular, backlog for:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Centrifugal pumps increased approximately $16,300 primarily due to strong order activity in the U.S. Navy and power generation markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Heat exchange coils increased approximately $5,400 primarily due to strong order intake for commercial OEMs; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Air handling units increased approximately $1,800 primarily due to strong order activity in the pharmaceutical market.

At March 31, 2026, approximately 28% of the segment's backlog is expected to ship after 2026.

------

**<u>Non-GAAP Financial Measures</u>** 

The Corporation presents non-GAAP adjusted EBITDA and non-GAAP adjusted income from operations. Non-GAAP adjusted EBITDA is calculated as net (loss) income excluding interest expense, other income - net, income tax provision, depreciation and amortization, and stock-based compensation along with significant charges or credits that are one-time charges or credits, unrelated to the Corporation's ongoing results of operations, or beyond its control. Non-GAAP adjusted income from operations is calculated as income from operations excluding depreciation and amortization and stock-based compensation along with significant charges or credits that are one-time charges or credits, unrelated to the segment's ongoing results of operations, or beyond its control. These non-GAAP financial measures were adjusted to exclude the Deconsolidation Charge. Additionally, these non-GAAP financial measures are not based on any standardized methodology prescribed by accounting principles generally accepted in the United States of America ("GAAP") and may not be comparable to similarly titled measures presented by other companies.

These measures are key measures used by the Corporation's management and Board of Directors to understand and evaluate the operating performance of the Corporation and its segments. The Corporation's management and Board of Directors believe these non-GAAP measures enhance comparability to companies in its stated industry peer group. Additionally, a portion of the incentive and compensation arrangements for certain employees is based on the Corporation's business performance.

The Corporation believes these non-GAAP financial measures help identify underlying trends in its business that otherwise could be masked by the effect of these items that it excludes from adjusted EBITDA and adjusted income from operations. The Corporation also believes these non-GAAP financial measures provide useful information to management, shareholders and investors, and others in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects and allowing for greater transparency with respect to key financial metrics used by the Corporation's management in its financial and operational decision-making. In particular, the Corporation believes the exclusion of the Deconsolidation Charge can provide a useful measure for period-to-period comparisons of the Corporation's core business performance.

Non-GAAP adjusted EBITDA and non-GAAP adjusted income from operations are not prepared in accordance with GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are limitations related to the use of non-GAAP adjusted EBITDA, rather than net (loss) income, or non-GAAP adjusted income from operations, rather than income from operations, which are the nearest GAAP equivalents. Among other things, there can be no assurance that additional expenses similar to the Deconsolidation Charge will not occur in future periods.

The adjustments reflected in non-GAAP adjusted income from operations are pre-tax. No income tax benefit was able to be recognized for these non-GAAP adjustments since the underlying operations remained in a three-year cumulative loss position as of March 31, 2026.

The following is a reconciliation of net (loss) income to non-GAAP adjusted EBITDA for the three months ended March 31, 2026 and 2025, respectively:

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 |
| Net (loss) income (GAAP) | $**(150)** | $1891 |
| *Add (deduct):* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | **2723** | 2726 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income – net | **(596)** | (826) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax provision | **585** | 59 |
| Income from operations (GAAP) | **2562** | 3850 |
| *Add (deduct):* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **4258** | 4636 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | **292** | 306 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deconsolidation Charge | **875** | - |
| Adjusted EBITDA (Non-GAAP) | $**7987** | $8792 |

---

------

The following is a reconciliation of income from operations to non-GAAP adjusted income from operations for the three months ended March 31, 2026 and 2025, respectively:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | **2026** | **2026** | **2026** | 2025 | 2025 | 2025 | 2025 |
|  | FCEP | ALP | Corp<sup>(1)</sup> | Consolidated | FCEP | ALP | Corp <sup>(1)</sup> | Consolidated |
| Income from operations (GAAP) | $906 | $5392 | $(3736) | $2562 | $3905 | $3494 | $(3549) | $3850 |
| *Add (deduct):* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 3924 | 327 | 7 | 4258 | 4368 | 268 |  | 4636 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  |  | 292 | 292 |  |  | 306 | 306 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deconsolidation Charge | 875 |  |  | 875 |  |  |  |  |
| Income from operations, as adjusted (Non-GAAP) | $4830 | $5719 | $(3437) | $7987 | $8273 | $3762 | $(3243) | $8792 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(1) Corporate represents the operating expenses of the corporate office and other costs not allocated to the segments.*

**<u>Liquidity and Capital Resources</u>** 

---

| | | | |
|:---|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|  | **2026** | 2025 | Change |
| Net cash flows provided by (used in) operating activities | $**1647** | $(5280) | $6927 |
| Net cash flows used in investing activities | **(3233)** | (1711) | (1522) |
| Net cash flows provided by (used in) financing activities | **182** | (1727) | 1909 |
| Effect of exchange rate changes on cash and cash equivalents | **(73)** | 420 | (493) |
| Net decrease in cash and cash equivalents | **(1477)** | (8298) | 6821 |
| Cash and cash equivalents at beginning of period | **10703** | 15427 | (4724) |
| Cash and cash equivalents at end of period | $**9226** | $7129 | $2097 |

---

<u>Net cash flows provided by (used in) operating activities</u> equaled $1,647 and $(5,280) for the three months ended March 31, 2026 and 2025, respectively, a change of $6,927 primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher customer-related liabilities, net of change in investment in contract assets, of approximately $3,400;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Lower net asbestos-related payments of approximately $1,300; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Collection of a portion of the Estimated Recovery of approximately $1,255.

Trade receivables at March 31, 2026 increased by approximately $14,600 when compared to trade receivables at December 31, 2025 primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher sales in February and March of 2026 versus November and December of 2025, which increased trade receivables by approximately $4,700 and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Receivable mix with such receivables having longer payment terms at March 31, 2026 when compared to the receivable mix at December 31, 2025.

Asbestos-related payments are expected to continue in the foreseeable future. The amount of asbestos-related payments and corresponding insurance recoveries are difficult to predict and can vary based on a number of factors, including changes in assumptions, as outlined in [<u>Note 15</u>](#note_15) to the condensed consolidated financial statements.

The Deconsolidation Charge of $875 recognized during the three months ended March 31, 2026 is a non-cash charge and did not impact net cash flows provided by (used in) operating activities.

<u>Net cash flows used in investing activities</u> equaled $(3,233) and $(1,711) for the three months ended March 31, 2026 and 2025, respectively, an increase of $(1,522) primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher capital expenditures of approximately $1,185, particularly by the ALP segment, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Lower government incentives, such as grants, of approximately $323 received by a division of the ALP segment for specific capital purchases.

At March 31, 2026, commitments for future capital expenditures approximated $8,400, which is expected to be spent over the next 12-18 months.

<u>Net cash flows provided by (used in) financing activities</u> equaled $182 and $(1,727) for the three months ended March 31, 2026 and 2025, respectively, a change of $1,909 which is primarily due to:

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Lower net repayments on the Corporation's revolving credit facility of $2,541 offset by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Higher repayment of debt principal of $632 in the current year.

The current portion of debt increased approximately $3,100 as of March 31, 2026 from December 31, 2025 due to higher balances outstanding as swing loans. Swing loans are temporary advances under the revolving credit facility and short-term in nature. Accordingly, swing loans are classified as a current liability until the amount is either repaid, as customers remit payments, or, if elected by the Corporation, refinanced as a longer-term loan under the revolving credit facility.

The effect of exchange rate changes on cash and cash equivalents is primarily attributable to the fluctuation of the Swedish krona and Chinese yuan against the U.S. dollar.

As a result of the above, cash and cash equivalents decreased by $1,477 during 2026 and ended the period at $9,226 in comparison to $10,703 at December 31, 2025. The majority of the Corporation's cash and cash equivalents is held by its foreign operations. Domestic customer remittances are used to repay borrowings under the Corporation's revolving credit facility daily, resulting in minimal cash maintained by the Corporation's domestic operations. Cash held by the Corporation's foreign operations is considered to be permanently re-invested; accordingly, a provision for estimated local and withholding tax has not been made. If the Corporation were to remit any foreign earnings to it or any of its U.S. entities, the estimated tax impact would be insignificant.

Funds on hand, funds generated from future operations and availability under the Corporation's revolving credit facility are expected to be sufficient to finance the Corporation's operational requirements, debt service costs, net asbestos payments, and capital expenditures. As of March 31, 2026, remaining availability under the revolving credit facility approximated $30,825, net of standard availability reserves. Since a significant portion of the Corporation's debt includes variable rate interest, increases in the underlying benchmark rates will increase the Corporation's debt service costs. Similarly, decreases in the underlying benchmark rates will decrease the Corporation's debt service costs.

The maturity date for the revolving credit facility is June 25, 2030 and, subject to the other terms and conditions of the revolving credit agreement, will become due on that date. Additionally, while the Corporation anticipates it has sufficient liquidity to finance the Corporation's operational requirements, debt service costs, net asbestos payments, and capital expenditures, it may from time to time consider alternatives, potential transactions and other strategies in an attempt to enhance its liquidity. Given such measures are forward-looking, the Corporation cannot ensure it will be successful in achieving such enhancements to improve its liquidity.

**<u>Litigation and Environmental Matters</u>** 

See [<u>Note 15</u>](#note_15) and [<u>Note 16</u>](#note_16) to the condensed consolidated financial statements.

**<u>Critical Accounting Policies</u>** 

The Corporation's critical accounting policies, as summarized in its Annual Report on Form 10-K for the year ended December 31, 2025, remain unchanged.

**<u>Recently Issued Accounting Pronouncements</u>** 

See [<u>Note 1</u>](#note_1) to the condensed consolidated financial statements.

------

**<u>ITEM 3 – QUANTITATIVE AND QUALITAT</u><u>IVE DISCLOSURES ABOUT MARKET RISK</u>**

Not applicable.

**<u>ITEM 4 – CONTROLS</u> <u>AND PROCEDURES</u>**

*Disclosure controls and procedures.* An evaluation of the effectiveness of the Corporation's disclosure controls and procedures as of the end of the period covered by this report was carried out under the supervision, and with the participation, of management, including the principal executive officer and principal financial officer. Disclosure controls and procedures are defined under Securities and Exchange Commission ("SEC") rules as controls and other procedures designed to ensure information required to be disclosed by a company in the reports it files under the Securities Exchange Act of 1934 (as amended, the "Exchange Act") is recorded, processed, summarized and reported within the required time periods. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure information required to be disclosed by an issuer in the reports it files or submits under the Exchange Act is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, the Corporation's management, including the principal executive officer and principal financial officer, has concluded the Corporation's disclosure controls and procedures were effective as of March 31, 2026.

*Changes in internal control.* There has been no change in the Corporation's internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 under the Exchange Act that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

------

**<u>PART II – OTHE</u><u>R INFORMATION</u>** 

**<u>AMPCO-PITTSBURGH CORPORATION</u>** 

Item 1 <u>Legal</u> <u>Proceedings</u> 

The information contained in [<u>Note 2</u>](#note_2) (UES-UK) and [<u>Note 15</u>](#note_15) (Litigation) to the condensed consolidated financial statements is incorporated herein by reference.

Item 1A <u>Ri</u><u>sk Factors</u> 

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A to our Annual Report on Form 10-K for the year ended December 31, 2025. The risk factors disclosed in Part I, Item 1A to our Annual Report on Form 10-K for the year ended December 31, 2025, in addition to the other information set forth in this report, could adversely affect the Corporation's operating performance and financial condition. Additional risks not currently known or deemed immaterial may also result in adverse effects on the Corporation.

Items 2-4 None.

Item 5 <u>Other Information</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) During the three months ended March 31, 2026, no director or officer of the Corporation adopted or terminated a 'Rule 10b5-1 trading arrangement' or 'non-Rule 10b5-1 trading arrangement,' with each term being defined in Item 408(a) of Regulation S-K.

------

Item 6 <u>E</u><u>xhibits</u> 

The following exhibits are filed as part of, or incorporated by reference into, this Form 10-Q.

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;(3.1) |  | &nbsp;&nbsp;[<u>Restated Articles of Incorporation, effective as of August 11, 2017, incorporated by reference to Quarterly Report on Form 10-Q filed on November 9, 2017.</u>](https://www.sec.gov/Archives/edgar/data/6176/000119312517338325/d435120dex101.htm) |
| &nbsp;&nbsp;(3.2) |  | &nbsp;&nbsp;[<u>Amendment of Amended and Restated Articles of Incorporation, effective as of May 9, 2019, incorporated by reference to Quarterly Report on Form 10-Q filed on May 10, 2019.</u>](https://www.sec.gov/Archives/edgar/data/6176/000156459019018430/ap-ex31_74.htm) |
| &nbsp;&nbsp;(3.3) |  | &nbsp;&nbsp;[<u>Amended and Restated By-Laws, effective June 4, 2024, incorporated by reference to Quarterly Report on Form 10-Q filed on August 12, 2024.</u>](https://www.sec.gov/Archives/edgar/data/6176/000095017024095513/ap-ex3_3.htm) |
| &nbsp;&nbsp;(31.1) | &nbsp;&nbsp;† | &nbsp;&nbsp;[<u>Certification of Principal Executive Officer pursuant to Section 302 of The Sarbanes-Oxley Act of 2002.</u>](ap-ex31_1.htm) |
| &nbsp;&nbsp;(31.2) | &nbsp;&nbsp;† | &nbsp;&nbsp;[<u>Certification of Principal Financial Officer pursuant to Section 302 of The Sarbanes-Oxley Act of 2002.</u>](ap-ex31_2.htm) |
| &nbsp;&nbsp;(32.1) | &nbsp;&nbsp;†† | &nbsp;&nbsp;[<u>Certification of Principal Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.</u>](ap-ex32_1.htm) |
| &nbsp;&nbsp;(32.2) | &nbsp;&nbsp;†† | &nbsp;&nbsp;[<u>Certification of Principal Financial Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.</u>](ap-ex32_2.htm) |
| &nbsp;&nbsp;(101.INS) | &nbsp;&nbsp;\* | &nbsp;&nbsp;Inline XBRL Instance Document |
| &nbsp;&nbsp;(101.SCH) | &nbsp;&nbsp;\*\* | &nbsp;&nbsp;Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Document |
| &nbsp;&nbsp;(104) |  | &nbsp;&nbsp;The cover page for the Corporation's Quarterly Report on Form 10-Q has been formatted in Inline XBRL and contained in Exhibit 101. |
| &nbsp;&nbsp;† |  | &nbsp;&nbsp;Filed herewith. |
| &nbsp;&nbsp;†† |  | &nbsp;&nbsp;Furnished herewith. |
| &nbsp;&nbsp;\* |  | &nbsp;&nbsp;The instance document does not appear in the Interactive Data File because its XBRL (Extensible Business Reporting Language) tags are embedded within the Inline XBRL document. |
| &nbsp;&nbsp;\*\* |  | &nbsp;&nbsp;Attached as Exhibit 101 to this report are the following documents formatted in Inline XBRL: (i) the Condensed Consolidated Balance Sheets at March 31, 2026 and December 31, 2025, (ii) the Condensed Consolidated Statements of Operations for the three months ended March 31, 2026 and 2025, (iii) the Condensed Consolidated Statements of Comprehensive (Loss) Income for the three months ended March 31, 2026 and 2025, (iv) the Condensed Consolidated Statements of Shareholders' Equity for the three months ended March 31, 2026 and 2025, (v) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025, and (vi) Notes to Condensed Consolidated Financial Statements. |

---

------

**<u>SIGNAT</u><u>URES</u>** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | AMPCO-PITTSBURGH CORPORATION | AMPCO-PITTSBURGH CORPORATION |
| DATE: May 12, 2026 | BY: | /s/ J. Brett McBrayer |
|  |  | J. Brett McBrayer |
|  |  | Director and Chief Executive Officer |
| DATE: May 12, 2026 | BY: | /s/ David G. Anderson |
|  |  | David G. Anderson |
|  |  | Vice President, Chief Financial Officer and Treasurer |

---

------

## Exhibit 31.1

**Exhibit 31.1** 

**Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** 

I, J. Brett McBrayer, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Form 10-Q of Ampco-Pittsburgh Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| <br>/s/ J. Brett McBrayer |
| J. Brett McBrayer |
| Director and Chief Executive Officer |
| May 12, 2026 |

---

------

## Exhibit 31.2

**Exhibit 31.2** 

**Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** 

I, David G. Anderson, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Form 10-Q of Ampco-Pittsburgh Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| <br>/s/ David G. Anderson |
| David G. Anderson |
| Vice President, Chief Financial Officer and Treasurer |
| May 12, 2026 |

---

------

## Exhibit 32.1

**Exhibit 32.1** 

**CERTIFICATION PURSUANT TO** 

**18 U.S.C. SECTION 1350** 

**AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of Ampco-Pittsburgh Corporation (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

---

| |
|:---|
| <br>/s/ J. Brett McBrayer |
| J. Brett McBrayer |
| Director and Chief Executive Officer |
| May 12, 2026 |

---

------

## Exhibit 32.2

**Exhibit 32.2** 

**CERTIFICATION PURSUANT TO** 

**18 U.S.C. SECTION 1350** 

**AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of Ampco-Pittsburgh Corporation (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

---

| |
|:---|
| <br>/s/ David G. Anderson |
| David G. Anderson |
| Vice President, Chief Financial Officer and <br>Treasurer |
| May 12, 2026 |

---

------